MCID: BNS003
MIFTS: 43

Binswanger's Disease

Categories: Mental diseases, Nephrological diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Binswanger's Disease

MalaCards integrated aliases for Binswanger's Disease:

Name: Binswanger's Disease 53 54
Multi-Infarct Dementia 53 72
Dementia Multi-Infarct 53 55
Binswanger Disease 55 72

Classifications:



External Ids:

UMLS 72 C0011263 C0270786

Summaries for Binswanger's Disease

NINDS : 54 Binswanger's disease (BD), also called subcortical vascular dementia, is a type of dementia caused by widespread, microscopic areas of damage to the deep layers of white matter in the brain. The damage is the result of the thickening and narrowing (atherosclerosis) of arteries that feed the subcortical areas of the brain. Atherosclerosis (commonly known as "hardening of the arteries") is a systemic process that affects blood vessels throughout the body. It begins late in the fourth decade of life and increases in severity with age. As the arteries become more and more narrowed, the blood supplied by those arteries decreases and brain tissue dies. A characteristic pattern of BD-damaged brain tissue can be seen with modern brain imaging techniques such as CT scans or magnetic resonance imaging (MRI). The symptoms associated with BD are related to the disruption of subcortical neural circuits that control what neuroscientists callexecutive cognitive functioning: short-term memory, organization, mood, the regulation of attention, the ability to act or make decisions, and appropriate behavior. The most characteristic feature of BD is psychomotor slowness - an increase in the length of time it takes, for example, for the fingers to turn the thought of a letter into the shape of a letter on a piece of paper. Other symptoms include forgetfulness (but not as severe as the forgetfulness of Alzheimer's disease), changes in speech, an unsteady gait, clumsiness or frequent falls, changes in personality or mood (most likely in the form of apathy, irritability, and depression), and urinary symptoms that aren't caused by urological disease. Brain imaging, which reveals the characteristic brain lesions of BD, is essential for a positive diagnosis.

MalaCards based summary : Binswanger's Disease, also known as multi-infarct dementia, is related to subcortical arteriosclerotic encephalopathy and aphasia. An important gene associated with Binswanger's Disease is SYP (Synaptophysin), and among its related pathways/superpathways are Neuroscience and Reelin Pathway (Cajal-Retzius cells). The drugs Acetaminophen and Buprenorphine have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and cortex, and related phenotypes are behavior/neurological and growth/size/body region

NIH Rare Diseases : 53 Binswanger's disease is a type of dementia caused by widespread, microscopic areas of damage to the deep layers of white matter in the brain. Most affected people experience progressive memory loss and deterioration of intellectual abilities (dementia); urinary urgency or incontinence; and an abnormally slow, unsteady gait (style of walking). While there is no cure, the progression of Binswanger's disease can be slowed with healthy lifestyle choices. Treatment is based on the signs and symptoms present in each person.

Related Diseases for Binswanger's Disease

Diseases related to Binswanger's Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 257, show less)
# Related Disease Score Top Affiliating Genes
1 subcortical arteriosclerotic encephalopathy 33.2 VIP GFAP
2 aphasia 29.9 MAPT APP APOE
3 hydrocephalus, normal-pressure 29.5 MAPT APOE
4 cerebral amyloid angiopathy, cst3-related 29.4 MAPT APP APOE
5 hydrocephalus 29.3 SYP MAPT GFAP APP APOE
6 vascular dementia 29.3 NOTCH3 MAPT APP APOE ACHE
7 dementia 29.1 NOTCH3 MAPT APP APOE ACHE
8 pick disease of brain 29.1 MAPT CHGA APP APOE
9 supranuclear palsy, progressive, 1 28.7 MAPT APP APOE ACHE
10 parkinson disease, late-onset 28.6 MAPT APP APOE ACHE
11 central nervous system disease 28.5 PLP1 MAPT GFAP APP APOE
12 cerebrovascular disease 28.4 NOTCH3 MAPT APP APOE ACHE
13 nervous system disease 27.8 SYP MAPT GFAP APP APOE ACHE
14 alzheimer disease 27.6 SYP MAPT GFAP CRH APP APOE
15 obsolete: binswanger disease 12.3
16 dementia - subcortical 11.6
17 cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 11.1
18 ureter small cell carcinoma 10.7 SYP CHGA
19 esophageal neuroendocrine tumor 10.7 SYP CHGA
20 urinary bladder small cell neuroendocrine carcinoma 10.7 SYP CHGA
21 encephalopathy 10.7
22 ovarian large-cell neuroendocrine carcinoma 10.7 SYP CHGA
23 auditory system cancer 10.7 SYP CHGA
24 acinar cell cystadenocarcinoma 10.7 SYP CHGA
25 primary hepatic neuroendocrine carcinoma 10.7 SYP CHGA
26 peritoneal serous adenocarcinoma 10.7 SYP CHGA
27 small cell carcinoma of the bladder 10.7 SYP CHGA
28 atypical follicular adenoma 10.7 SYP CHGA
29 malignant glandular tumor of peripheral nerve sheath 10.7 SYP SST
30 gallbladder small cell carcinoma 10.7 SYP CHGA
31 pulmonary large cell neuroendocrine carcinoma 10.7 SYP CHGA
32 olfactory groove meningioma 10.7 SYP CHGA
33 cauda equina neoplasm 10.7 SYP CHGA
34 pancreatic somatostatinoma 10.7 SYP SST
35 conventional angiosarcoma 10.7 SYP CHGA
36 pancreatic serous cystadenoma 10.7 SYP CHGA
37 gastrointestinal neuroendocrine benign tumor 10.7 SST CHGA
38 olfactory nerve neoplasm 10.6 SYP CHGA
39 gastric neuroendocrine neoplasm 10.6 SST CHGA
40 extraventricular neurocytoma 10.6 SYP GFAP
41 desmoplastic infantile ganglioglioma 10.6 SYP GFAP
42 myofibromatosis, infantile, 1 10.6 NOTCH3 ACTC1
43 nodular ganglioneuroblastoma 10.6 SYP CHGA
44 pancreatic endocrine carcinoma 10.6 SYP SST
45 anaplastic ganglioglioma 10.6 GFAP ACTC1
46 lung combined type small cell carcinoma 10.6 SYP GFAP
47 glycogen-rich clear cell breast carcinoma 10.6 SYP ACTC1
48 pulmonary sclerosing hemangioma 10.6 SYP CHGA
49 cutaneous leiomyosarcoma 10.6 GFAP ACTC1
50 non-langerhans-cell histiocytosis 10.6 SST ACTC1
51 sclerosing hemangioma 10.6 SYP CHGA
52 syringocystadenoma papilliferum 10.6 GFAP ACTC1
53 parachordoma 10.6 GFAP ACTC1
54 chiari malformation 10.6 SYP GFAP
55 insulinomatosis and diabetes mellitus 10.6 SST CHGA
56 clear cell ependymoma 10.6 SYP GFAP
57 central nervous system primitive neuroectodermal neoplasm 10.6 SYP GFAP
58 cerebral neuroblastoma 10.6 SYP GFAP
59 dysembryoplastic neuroepithelial tumor 10.6 SYP GFAP
60 gastric small cell carcinoma 10.6 SYP CHGA
61 astroblastoma 10.6 SYP GFAP
62 subependymal glioma 10.6 SYP GFAP
63 perivascular epithelioid cell tumor 10.6 SYP ACTC1
64 anterior cranial fossa meningioma 10.6 SYP CHGA
65 pineal gland cancer 10.6 SYP GFAP
66 cerebral ventricle cancer 10.5 SYP GFAP
67 clear cell meningioma 10.5 GFAP CHGA
68 respiratory system benign neoplasm 10.5 SYP CHGA
69 benign ependymoma 10.5 SYP GFAP
70 horseshoe kidney 10.5 SYP CHGA ACTC1
71 melanotic neuroectodermal tumor 10.5 SYP GFAP
72 granulosa cell tumor of the ovary 10.5 SYP CHGA ACTC1
73 gastric squamous cell carcinoma 10.5 SYP CHGA
74 non-functioning pancreatic endocrine tumor 10.5 SYP CHGA
75 medulloepithelioma 10.5 SYP GFAP
76 gastrointestinal neuroendocrine tumor 10.5 SYP SST CHGA
77 pulmonary blastoma 10.5 SYP CHGA
78 neuroendocrine tumor 10.5 SYP SST CHGA
79 pancreatoblastoma 10.5 SYP SST CHGA
80 carcinoid tumors, intestinal 10.5 SYP SST CHGA
81 obstructive hydrocephalus 10.5 SYP GFAP
82 carcinoid syndrome 10.5 SYP SST CHGA
83 mixed ductal-endocrine carcinoma 10.5 SYP SST CHGA
84 hemangioma 10.5 SYP CHGA ACTC1
85 malignant pheochromocytoma 10.5 SYP SST CHGA
86 anaplastic ependymoma 10.5 SYP GFAP
87 endocrine organ benign neoplasm 10.5 SYP SST CHGA
88 hypoganglionosis 10.5 SYP ACHE
89 merkel cell carcinoma 10.5 SYP SST CHGA
90 paraganglioma 10.5 SYP SST CHGA
91 congenital hydrocephalus 10.4
92 wdha syndrome 10.4 VIP SST
93 angiocentric glioma 10.4 SYP GFAP ACTC1
94 cellular ependymoma 10.4 SYP GFAP CHGA
95 chordoid meningioma 10.4 SYP GFAP CHGA
96 pineocytoma 10.4 SYP GFAP CHGA
97 subependymoma 10.4 SYP GFAP CHGA
98 urethral benign neoplasm 10.4 CHGA APP
99 papillary ependymoma 10.4 SYP GFAP CHGA
100 tanycytic ependymoma 10.4 SYP GFAP CHGA
101 pleomorphic xanthoastrocytoma 10.4 SYP GFAP CHGA
102 postgastrectomy syndrome 10.4 VIP SST
103 central neurocytoma 10.4 SYP GFAP CHGA
104 small cell cancer of the lung 10.4 SYP SST CHGA
105 cerebellar liponeurocytoma 10.4 SYP GFAP CHGA
106 senile plaque formation 10.4 APP APOE
107 ganglioglioma 10.4 SYP GFAP CHGA
108 vascular disease 10.4
109 gastrointestinal stromal tumor 10.4 SYP CHGA ACTC1
110 teratoma 10.4 SYP GFAP ACTC1
111 duodenal gastrinoma 10.4 SST CHGA
112 alzheimer's disease 1 10.4 APP APOE
113 childhood oligodendroglioma 10.4 SYP GFAP
114 glomus tumor 10.4 SYP ACTC1
115 functional colonic disease 10.4 SYP SST
116 gangliocytoma 10.4 SYP CRH
117 allergic encephalomyelitis 10.3 PLP1 CRH
118 gait apraxia 10.3 APP APOE
119 meningioma, familial 10.3 SYP SST GFAP
120 pineoblastoma 10.3 SYP GFAP
121 arteriosclerosis 10.3
122 cerebral degeneration 10.3 PLP1 NOTCH3 GFAP
123 autonomic nervous system benign neoplasm 10.3 VIP SYP CHGA
124 atypical choroid plexus papilloma 10.3 SYP NOTCH3 APP
125 nelson syndrome 10.2 SST CRH
126 colonic pseudo-obstruction 10.2 SYP SST ACHE
127 pancreatic cholera 10.2 VIP SST
128 glucagonoma 10.2 VIP SST CHGA
129 vipoma 10.2 VIP SST CHGA
130 somatostatinoma 10.2 VIP SST CHGA
131 gastrinoma 10.2 VIP SST CHGA
132 islet cell tumor 10.2 VIP SST CHGA
133 nominal aphasia 10.2
134 pseudobulbar palsy 10.2
135 arteriolosclerosis 10.2
136 depression 10.2
137 papilloma of choroid plexus 10.2 SYP GFAP
138 ectopic cushing syndrome 10.1 SYP SST CRH
139 adrenocortical carcinoma, hereditary 10.1 SYP CRH CHGA
140 temporal arteritis 10.1
141 amnestic disorder 10.1
142 bronchopneumonia 10.1
143 alexia 10.1
144 agnosia 10.1
145 lupus erythematosus 10.1
146 47,xyy 10.1
147 cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 10.1
148 cerebral arteriopathy, autosomal recessive, with subcortical infarcts and leukoencephalopathy 10.1
149 apraxia 10.1
150 cerebral atherosclerosis 10.1
151 antiphospholipid syndrome 10.1
152 peripheral nervous system neoplasm 10.1 VIP SYP APP
153 spinocerebellar degeneration 10.1 SST CRH
154 postencephalitic parkinson disease 10.1 SYP MAPT
155 simultanagnosia 10.1 MAPT APOE
156 posterior cortical atrophy 10.0 MAPT APOE
157 multiple endocrine neoplasia, type i 10.0 VIP SYP SST CHGA
158 endocrine gland cancer 10.0 VIP SYP SST CHGA
159 semantic dementia 10.0 MAPT APOE
160 toxic encephalopathy 10.0 GFAP APP ACHE
161 alcohol dependence 9.9
162 huntington disease 9.9
163 systemic lupus erythematosus 9.9
164 migraine with or without aura 1 9.9
165 platelet membrane fluidity 9.9
166 thrombophilia due to thrombin defect 9.9
167 stroke, ischemic 9.9
168 alzheimer disease 5 9.9
169 alzheimer disease 7 9.9
170 alzheimer disease 8 9.9
171 aplastic anemia 9.9
172 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.9
173 electroclinical syndrome 9.9
174 vitamin b12 deficiency 9.9
175 diffuse large b-cell lymphoma 9.9
176 associative agnosia 9.9
177 finger agnosia 9.9
178 tactile agnosia 9.9
179 visual agnosia 9.9
180 agraphia 9.9
181 lymphoproliferative syndrome 9.9
182 hemiplegia 9.9
183 vertebral artery occlusion 9.9
184 dyscalculia 9.9
185 carotid stenosis 9.9
186 vertebrobasilar insufficiency 9.9
187 rheumatic disease 9.9
188 histoplasmosis 9.9
189 optic nerve disease 9.9
190 enthesopathy 9.9
191 constipation 9.9
192 transient cerebral ischemia 9.9
193 syphilis 9.9
194 glucose metabolism disease 9.9
195 dysgraphia 9.9
196 ideomotor apraxia 9.9
197 central nervous system vasculitis 9.9
198 sleep disorder 9.9
199 aortic valve insufficiency 9.9
200 b-cell lymphoma 9.9
201 delusional disorder 9.9
202 carotid artery occlusion 9.9
203 subacute delirium 9.9
204 vasculitis 9.9
205 chickenpox 9.9
206 behavioral variant of frontotemporal dementia 9.9
207 pseudobulbar affect 9.9
208 head injury 9.9
209 tremor 9.9
210 antiphospholipid syndrome, familial 9.9
211 creutzfeldt-jakob disease 9.9
212 hand skill, relative 9.9
213 hydrocephalus, congenital, 1 9.9
214 ocular motor apraxia 9.9
215 pseudoxanthoma elasticum 9.9
216 ataxia and polyneuropathy, adult-onset 9.9
217 hemorrhage, intracerebral 9.9
218 sleep apnea 9.9
219 asymptomatic neurosyphilis 9.9
220 visual epilepsy 9.9
221 porphyria 9.9
222 mental depression 9.9
223 encephalomalacia 9.9
224 acute porphyria 9.9
225 demyelinating disease 9.9
226 mood disorder 9.9
227 mutism 9.9
228 akinetic mutism 9.9
229 brain edema 9.9
230 speech disorder 9.9
231 hypertensive encephalopathy 9.9
232 neurosyphilis 9.9
233 pure autonomic failure 9.9
234 cerebral arteriosclerosis 9.9
235 cerebral atrophy 9.9
236 seizure disorder 9.9
237 syncope 9.9
238 ganglioneuroma 9.9 VIP SYP GFAP CHGA
239 cell type benign neoplasm 9.9 SYP SST CRH CHGA
240 hirschsprung disease 1 9.9 VIP SYP ACHE
241 wernicke encephalopathy 9.9 MAPT GFAP
242 irritable bowel syndrome 9.9 VIP CRH CHGA
243 kluver-bucy syndrome 9.9 MAPT APP
244 pituitary carcinoma 9.8 SST GFAP CRH CHGA
245 brain injury 9.7 MAPT GFAP APOE
246 benign familial neonatal epilepsy 9.7 GFAP CRH
247 kohlschutter-tonz syndrome 9.7 MAPT APP APOE
248 leukoencephalopathy, hereditary diffuse, with spheroids 9.7 MAPT GFAP APP
249 alzheimer disease mitochondrial 9.7 MAPT APP APOE
250 alzheimer disease 2 9.6 MAPT APP APOE
251 communicating hydrocephalus 9.6 MAPT APOE
252 inclusion body myositis 9.6 MAPT APP APOE
253 pheochromocytoma 9.4 VIP SYP SST CRH CHGA
254 amyotrophic lateral sclerosis 1 9.4 SYP MAPT GFAP APP
255 frontotemporal dementia 9.2 MAPT APP APOE ACHE
256 disease of mental health 9.1 MAPT CRH APP APOE
257 dementia, lewy body 9.0 SYP MAPT APP APOE ACHE

Graphical network of the top 20 diseases related to Binswanger's Disease:



Diseases related to Binswanger's Disease

Symptoms & Phenotypes for Binswanger's Disease

MGI Mouse Phenotypes related to Binswanger's Disease:

46 (showing 13, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 10.26 ACHE APOE APP CRH GFAP MAPT
2 growth/size/body region MP:0005378 10.26 ACHE ACTC1 APOE APP CHGA CRH
3 homeostasis/metabolism MP:0005376 10.23 ACHE ACTC1 APOE APP CHGA CRH
4 mortality/aging MP:0010768 10.18 ACHE ACTC1 APOE APP CHGA GFAP
5 cardiovascular system MP:0005385 10.16 ACTC1 APOE APP CHGA GFAP MAPT
6 cellular MP:0005384 10.15 ACTC1 APOE APP CRH GFAP MAPT
7 nervous system MP:0003631 10.1 ACHE APOE APP CHGA CRH GFAP
8 immune system MP:0005387 10.09 APOE APP CRH GFAP MAPT NOTCH3
9 muscle MP:0005369 10.02 ACHE ACTC1 APOE APP CHGA GFAP
10 normal MP:0002873 9.81 ACTC1 APP CRH GFAP MAPT NOTCH3
11 no phenotypic analysis MP:0003012 9.8 ACHE APOE APP CHGA CRH MAPT
12 reproductive system MP:0005389 9.5 ACHE APOE APP CHGA NOTCH3 PLP1
13 vision/eye MP:0005391 9.17 ACHE APOE GFAP MAPT NOTCH3 PLP1

Drugs & Therapeutics for Binswanger's Disease

Drugs for Binswanger's Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 18, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Acetaminophen Approved Phase 4 103-90-2 1983
2
Buprenorphine Approved, Illicit, Investigational, Vet_approved Phase 4 52485-79-7 40400 644073
3 Analgesics, Non-Narcotic Phase 4
4 Narcotics Phase 4
5 Peripheral Nervous System Agents Phase 4
6 Analgesics Phase 4
7 Narcotic Antagonists Phase 4
8 Central Nervous System Depressants Phase 4
9 Antipyretics Phase 4
10 Analgesics, Opioid Phase 4
11
Serine Approved, Nutraceutical Phase 2 56-45-1 5951
12
Dabigatran Investigational Phase 2 211914-51-1
13 Antithrombin III Phase 2
14
protease inhibitors Phase 2
15 HIV Protease Inhibitors Phase 2
16 Serine Proteinase Inhibitors Phase 2
17 Antithrombins Phase 2
18 Anticoagulants Phase 2

Interventional clinical trials:

(showing 9, show less)
# Name Status NCT ID Phase Drugs
1 Efficacy of Pain Treatment on Depression in Patients With Dementia. A Randomized Clinical Trial. Completed NCT02267057 Phase 4 Paracetamol;Buprenorphine;Paracetamol placebo;Buprenorphine placebo
2 Phase II, Randomized, Crossover, Single Blind, Safety Trial of DABIGATRAN Versus ASA for Preventing Ischaemic Brain Lesions in Patients Affected by CADASIL Unknown status NCT01361763 Phase 2 Dabigatran;Antiplatelets
3 Etude Comparative en Imagerie Par résonnance magnétique et Par Enregistrement électroencéphalographique du Couplage Neurovasculaire Dans l'Angiopathie Cadasil Unknown status NCT02071784
4 Obtention d'un modèle Cellulaire de la Maladie CADASIL à Partir de Fibroblastes cutanés de Patients Unknown status NCT02032225
5 Natural History of CADASIL: Migraine, Diagnosis and Misdiagnosis Completed NCT01114815
6 The Genetic Characterization of Dementia Completed NCT01867359
7 Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study Recruiting NCT03724136
8 CADASIL Disease Discovery Active, not recruiting NCT02821780
9 Développement de Nouveaux Biomarqueurs en Imagerie Par résonance magnétique Pour Les études Longitudinales Dans l'Angiopathie CADASIL Not yet recruiting NCT04036084

Search NIH Clinical Center for Binswanger's Disease

Genetic Tests for Binswanger's Disease

Anatomical Context for Binswanger's Disease

MalaCards organs/tissues related to Binswanger's Disease:

41
Brain, Testes, Cortex, Endothelial, Eye, Smooth Muscle, Cerebellum

Publications for Binswanger's Disease

Articles related to Binswanger's Disease:

(showing 1161, show less)
# Title Authors PMID Year
1
Hereditary multi-infarct dementia of the Swedish type is a novel disorder different from NOTCH3 causing CADASIL. 9 38
17235124 2007
2
Metallothionein I-II immunocytochemical reactivity in Binswanger's encephalopathy. 9 38
12515897 2002
3
Schizophrenia in a patient with cerebral autosomally dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL disease). 9 38
11827605 2001
4
An CSF anamalous molecular form of acetylcholinesterase in demented and non-demented subjects. 9 38
9351648 1997
5
Alterations in glia and axons in the brains of Binswanger's disease patients. 9 38
9227695 1997
6
Apolipoprotein E genotypes and serum lipid levels in Alzheimer's disease and multi-infarct dementia. 9 38
9152721 1997
7
Apolipoprotein E genotype and Alzheimer's disease in Hong Kong elderly Chinese. 9 38
8559364 1996
8
Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele. 9 38
7986172 1994
9
Synaptophysin immunoreactivity of the cortical neuropil in vascular dementia of Binswanger type compared with the dementia of Alzheimer type and nondemented controls. 9 38
8038870 1994
10
Effect of CDP-choline on cognition and immune function in Alzheimer's disease and multi-infarct dementia. 9 38
8239305 1993
11
Cerebrospinal fluid corticotropin-releasing hormone and ACTH, and peripherally circulating choline-containing phospholipid in senile dementia. 9 38
8394971 1993
12
Interleukin-1 in Alzheimer's disease and multi-infarct dementia: neuropsychological correlations. 9 38
1770834 1991
13
Quantitative changes in the amyloid beta A4 precursor protein in Alzheimer cerebrospinal fluid. 9 38
1677459 1991
14
Neuropeptides in cerebrospinal fluid in normal-pressure hydrocephalus and dementia. 9 38
1675171 1991
15
Cerebrospinal fluid and plasma corticotropin-releasing hormone in senile dementia. 9 38
1645837 1991
16
Neuro-regeneration Therapeutic for Alzheimer's Dementia: Perspectives on Neurotrophic Activity. 38
31402121 2019
17
Intracerebral Transcatheter Laser Photobiomodulation Therapy in the Treatment of Binswanger's Disease and Vascular Parkinsonism: Research and Clinical Experience. 38
31390288 2019
18
Biomarkers identify the Binswanger type of vascular cognitive impairment. 38
29513153 2019
19
In search of multimodal brain alterations in Alzheimer's and Binswanger's disease. 38
31351845 2019
20
X-Linked Lymphoproliferative Syndrome Presenting as Adult-Onset Multi-Infarct Dementia. 38
30990878 2019
21
A case of hypertension with dementia: Common but underdiagnosed. 38
30090792 2018
22
Binswanger's disease: biomarkers in the inflammatory form of vascular cognitive impairment and dementia. 38
28902409 2018
23
Driving and Patients With Dementia. 38
29900187 2018
24
Multi-infarct dementia of Swedish type is caused by a 3'UTR mutation of COL4A1. 38
28369186 2017
25
Extracellular matrix inflammation in vascular cognitive impairment and dementia. 38
28265034 2017
26
Multi-Infarct Dementia: A Historical Perspective. 38
28626470 2017
27
[Degenerative cerebellar diseases and differential diagnoses]. 38
27783098 2016
28
The pathophysiological role of astrocytic endothelin-1. 38
27132521 2016
29
Elevation of the ACTH/cortisol ratio in female opioid dependent patients: A biomarker of aging and correlate of metabolic and immune activation. 38
27857051 2016
30
Quantitative EEG Neurometric Analysis-Guided Neurofeedback Treatment in Dementia: 20 Cases. How Neurometric Analysis Is Important for the Treatment of Dementia and as a Biomarker? 38
26099949 2016
31
Matrix Metalloproteinase-Mediated Neuroinflammation in Vascular Cognitive Impairment of the Binswanger Type. 38
26993507 2016
32
[Effects of Tongluo Xingnao effervescent tablets on blood rheology, iNOS, VEGF and LDH-5 in MID rats]. 38
28875680 2016
33
Animal Models of Vascular Cognitive Impairment and Dementia (VCID). 38
26988696 2016
34
Multi-infarct dementia and Alzheimer disease, contribution of cerebral circulation ultrasonography to pathogenesis and differential diagnosis. Value of microembolisation. 38
27179577 2016
35
The risk of overweight/obesity in mid-life and late life for the development of dementia: a systematic review and meta-analysis of longitudinal studies. 38
26764391 2016
36
Consensus statement for diagnosis of subcortical small vessel disease. 38
26198175 2016
37
Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus? 38
26124236 2015
38
Ekbom syndrome occurring with multi infarct dementia. 38
26023627 2015
39
Progressive cognitive deficits in a mouse model of recurrent photothrombotic stroke. 38
25744521 2015
40
Cerebral small vessel disease and Alzheimer's disease. 38
26604717 2015
41
MRI features of Binswanger's disease predict prognosis and associated pathology. 38
25493272 2014
42
Binswanger's disease: toward a diagnosis agreement and therapeutic approach. 38
25201523 2014
43
Cognitive profiles in patients with multi-infarct dementia: an omani study. 38
25202321 2014
44
Behavioural and psychological symptoms in poststroke vascular cognitive impairment. 38
24825957 2014
45
Effects of acupuncture on declined cerebral blood flow, impaired mitochondrial respiratory function and oxidative stress in multi-infarct dementia rats. 38
24361538 2014
46
Comparison of medial temporal measures between Binswanger's disease and Alzheimer's disease. 38
24466084 2014
47
Quantitative vascular pathology and phenotyping familial and sporadic cerebral small vessel diseases. 38
23387519 2013
48
Etiological pattern of demented patients attending in a tertiary hospital. 38
23982539 2013
49
Prostaglandin D2 synthase: Apoptotic factor in alzheimer plasma, inducer of reactive oxygen species, inflammatory cytokines and dialysis dementia. 38
24475446 2013
50
[Current concepts in vascular dementia]. 38
23803634 2013
51
A meta-analysis of Chinese herbal medicines for vascular dementia. 38
25206465 2013
52
Rivastigmine for vascular cognitive impairment. 38
23728651 2013
53
Ginkgo biloba: indications, mechanisms, and safety. 38
23538078 2013
54
Citrulline: pharmacological perspectives and its role as an emerging biomarker in future. 38
23316808 2013
55
Bacteremia due to Staphylococcus cohnii ssp. urealyticus caused by infected pressure ulcer: case report and review of the literature. 38
23538597 2013
56
Childhood trauma and PTSD symptoms increase the risk of cognitive impairment in a sample of former indentured child laborers in old age. 38
23469076 2013
57
Varicella zoster virus vasculopathy: a treatable form of rapidly progressive multi-infarct dementia after 2 years' duration. 38
22935406 2012
58
Nuclear medicine in cerebrovascular disease. 38
23026361 2012
59
[Effect of sailuotong capsule on intervening cognitive dysfunction of multi-infarct dementia in rats]. 38
23270238 2012
60
Vascular cognitive impairment and dementia expenditures: 7-year inpatient cost description in community dwellers. 38
23095429 2012
61
Phase II study of Ginkgo biloba in irradiated brain tumor patients: effect on cognitive function, quality of life, and mood. 38
22700031 2012
62
Morphometric characterization of Binswanger's disease: comparison with Alzheimer's disease. 38
21708443 2012
63
Vascular psychosis in the elderly: response to clozapine. 38
22851482 2012
64
The assessment of changes in cognitive functioning in the elderly: age- and education-specific reliable change indices for the SIDAM. 38
22414525 2012
65
Subcortical vascular dementia. 38
21821070 2011
66
Primary antiphospholipid antibody syndrome presenting with encephalopathy, psychosis and seizures. 38
21768180 2011
67
[Vascular dementia: big effects of small lesions]. 38
22164676 2011
68
[Biography and dementia. Origin of challenging behavior in patients with multi-infarct dementia or senile dementia of the Alzheimer type in long term care with reference the biographical level]. 38
22032036 2011
69
[What is cerebral small vessel disease?]. 38
21735731 2011
70
Effects of acupuncture on glycometabolic enzymes in multi-infarct dementia rats. 38
21279683 2011
71
Urinary tract infection in very old women is associated with delirium. 38
20716391 2011
72
[Clinical and imaging diagnostics of Parkinson's disease and multiple system atrophy]. 38
21431458 2011
73
Vascular cognitive impairment in small vessel disease: clinical and neuropsychological features of lacunar state and Binswanger's disease. 38
21239411 2011
74
Trichotillomania in a dementia case. 38
29213722 2011
75
Vascular cognitive disorder. A biological and clinical overview. 38
21127967 2010
76
Experimental models of vascular dementia and vascular cognitive impairment: a systematic review. 38
20731763 2010
77
The clinical manifestations and pathophysiology of cerebral small vessel disease. 38
20502505 2010
78
Imaging in neurodegenerative disorders. 38
20171344 2010
79
Prevalence and factors associated with urinary tract infections (UTIs) in very old women. 38
19349084 2010
80
Binswanger's disease and quantitative fractional anisotropy. 38
19547805 2009
81
Noninvasive biomarkers in normal pressure hydrocephalus: evidence for the role of neuroimaging. 38
18991499 2009
82
Planum temporale analysis via a new volumetric method in autoptic brains of demented and psychotic patients. 38
19199877 2009
83
[Eleven years of autopsy on account of Creutzfeldt-Jakob disease in the Netherlands]. 38
19785859 2009
84
[Molecular imaging of cerebral blood flow and metabolism with SPET and PET in principal dementias]. 38
19330195 2009
85
Susceptibility weighted imaging: a new tool in magnetic resonance imaging of stroke. 38
19070701 2009
86
Dementia and leukoencephalopathy due to lymphomatosis cerebri. 38
21686648 2009
87
The concept of vascular cognitive impairment. 38
19182465 2009
88
[Functional imaging in Binswanger's disease]. 38
19198127 2008
89
Stroke and multi-infarct dementia as presenting symptoms of giant cell arteritis: report of 7 cases and review of the literature. 38
19011505 2008
90
Lateralization of hippocampal nitric oxide mediator system in people with Alzheimer disease, multi-infarct dementia and schizophrenia. 38
18647632 2008
91
The corpus callosum in Binswanger's disease: A quantitative fractional anisotropy analysis. 38
29213585 2008
92
Different responses to rivastigmine in subcortical vascular dementia and multi-infarct dementia. 38
18184948 2008
93
[Cognitive impairment in patients with idiopathic normal pressure hydrocephalus]. 38
18402069 2008
94
Vascular cognitive impairment: current concepts and clinical developments. 38
18275926 2008
95
[Update on vascular dementias]. 38
18342055 2008
96
Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer's disease from Binswanger's disease. 38
18617735 2008
97
The clinical spectrum of freezing of gait in atypical parkinsonism. 38
18668624 2008
98
Lateralization of 17beta-hydroxysteroid dehydrogenase type 10 in hippocampi of demented and psychotic people. 38
18765932 2008
99
Vascular cognitive impairment: prodromal stages of ischemic vascular dementia. 38
18401174 2008
100
Capillary beds are decreased in Alzheimer's disease, but not in Binswanger's disease. 38
17403574 2007
101
Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation. 38
17504105 2007
102
Protective effects of Nicotiflorin on reducing memory dysfunction, energy metabolism failure and oxidative stress in multi-infarct dementia model rats. 38
17448528 2007
103
Binswanger's disease. 38
17694788 2007
104
Cross-cultural studies using a modified mini mental test for healthy subjects and patients with various forms of vascular dementia. 38
17258132 2007
105
Modern concept of vascular cognitive impairment. 38
17675645 2007
106
Gait apraxia: further clues to localization. 38
17622719 2007
107
Vascular cognitive deterioration and stroke. 38
17971655 2007
108
Comparison of regional cerebral blood flow in two subsets of subcortical ischemic vascular dementia: statistical parametric mapping analysis of SPECT. 38
16996088 2006
109
[Progressive subcortical vascular encephalopathy of the Binswanger type and multi-infarct dementia]. 38
17471663 2006
110
White matter changes in elderly people: MR-pathologic correlations. 38
17008766 2006
111
Brain volume changes in CADASIL: a serial MRI study in pure subcortical ischemic vascular disease. 38
16717211 2006
112
Ischemic demyelination. 38
16687062 2006
113
[Pathophysiology and therapeutic approaches on Binswanger's disease]. 38
16681257 2006
114
Small vessel disease and subcortical vascular dementia. 38
20396480 2006
115
[Effects of acupuncture on expression CuZnSOD mRNA and protein in hippocampus of the rat with multi-infarct dementia]. 38
16541866 2006
116
Galantamine for vascular cognitive impairment. 38
23862185 2006
117
[An 81-year-old man with personality change, dementia, and gait disturbance with diffuse leukoaraiosis of the cerebral white matter]. 38
16482927 2006
118
Small artery dementia in Japan: radiological differences between CADASIL, leukoaraiosis and Binswanger's disease. 38
16391479 2006
119
Metallothionein-I-II and GFAP positivity in the brains from frontotemporal dementia patients. 9
16308479 2005
120
Acupuncture improved cognitive impairment caused by multi-infarct dementia in rats. 38
16181648 2005
121
Giant cell arteritis--presenting as stroke, transient ischaemic attack and dementia. 38
16113702 2005
122
Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence. 38
16024750 2005
123
Childhood conduct problems, stages of Alzheimer's disease, and physical aggression against caregivers. 38
15852459 2005
124
EEG mapping and low-resolution brain electromagnetic tomography (LORETA) in diagnosis and therapy of psychiatric disorders: evidence for a key-lock principle. 38
15999906 2005
125
The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism. 38
15974913 2005
126
Rivastigmine for vascular cognitive impairment. 38
15846730 2005
127
[Clinico-pathology and differential diagnosis of Binswanger's disease]. 38
15887411 2005
128
Emission tomography in dementia. 38
15722899 2005
129
Lymphomatosis cerebri as a cause of white matter dementia. 38
15791573 2005
130
The underdiagnosis of the vascular contribution to dementia. 38
15760612 2005
131
[Distribution of ischemic leukoaraiosis in MRI: a difference from white matter lesions in CADASIL]. 38
15856758 2005
132
Time course and sequence of pathological changes in the cerebellum of microsphere-embolized rats. 38
15649481 2005
133
Association between global brain volume and the rate of cognitive change in elderly humans without dementia. 38
15677869 2005
134
Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients. 38
15367749 2005
135
[A case of early stage CADASIL showing only dizziness and vertigo with a novel mutation of Notch 3 gene]. 38
15714997 2005
136
Uncommon causes of cerebrovascular dementia. 38
16240483 2005
137
Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders. 38
15665416 2004
138
Evaluation of insomnia and daytime napping in Iranian Alzheimer disease patients: relationship with severity of dementia and comparison with normal adults. 38
15353390 2004
139
A two-year clinical follow-up study in 80 CADASIL subjects: progression patterns and implications for clinical trials. 38
15155961 2004
140
Communicative responsibility and semantic task in the language of adults with dementia. 38
15291204 2004
141
Some observations on the spectrum of dementia. 38
15269474 2004
142
Topographical and cytopathological lesion analysis of the white matter in Binswanger's disease brains. 38
15088098 2004
143
Cerebral blood flow patterns in Binswanger's disease: a SPECT study using three-dimensional stereotactic surface projections. 38
15140610 2004
144
Different mechanisms of corpus callosum atrophy in Alzheimer's disease and vascular dementia. 38
15083283 2004
145
Acute unilateral visual loss as the first symptom of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. 38
15096408 2004
146
[Vascular dementia and vascular cognitive impairment]. 38
15171562 2004
147
Pathology of the cerebral artery in Binswanger's disease in the aged: observation by serial sections and morphometry of the cerebral arteries. 38
15068169 2004
148
Questions & answers. We've been told that my wife has multi-infarct dementia and that the new drug memantine may help. How is her condition different from Alzheimer's disease, and what could memantine do for her? 38
15044129 2004
149
From Binswanger's disease to leuokoaraiosis: what we have learned about subcortical vascular dementia. 38
15595361 2004
150
The clinical diagnosis of vascular dementia: A comparison among four classification systems and a proposal for a new paradigm. 38
15595354 2004
151
[An autopsy case with dementia with Lewy bodies accompanied by Binswanger's disease--like changes]. 38
15098365 2004
152
[Binswanger's disease]. 38
15011377 2004
153
Risk of dementia and alcohol and wine consumption: a review of recent results. 38
15455646 2004
154
Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial. 38
14663654 2003
155
Is dementia a disease? 38
14624068 2003
156
Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. 38
12847154 2003
157
[The model of stroke induced by microsphere embolism in rats]. 38
12835538 2003
158
Binswanger's disease: its association with hypertension and obstructive sleep apnea. 38
12858817 2003
159
Vascular dementia: distinguishing characteristics, treatment, and prevention. 38
12801386 2003
160
Cerebral microbleeds in Binswanger's disease: a gradient-echo T2*-weighted magnetic resonance imaging study. 38
12672544 2003
161
[Leukoaraiosis. Clinical importance and prognosis]. 38
12677481 2003
162
Vascular cognitive impairment. 38
12849265 2003
163
APS and the brain. 38
14714905 2003
164
Transcutaneous electrical nerve stimulation (TENS) for dementia. 38
12917999 2003
165
Vascular dementia. 38
22470255 2003
166
Neuropathology of vascular cognitive impairment and vascular dementia. 38
16191220 2003
167
Regulatory issues in vascular dementia: a European perspective. 38
16191258 2003
168
Serial CT and MRI findings in a patient with isolated angiitis of the central nervous system associated with cerebral amyloid angiopathy. 38
12557755 2002
169
[Age- and education-specific reference values for the cognitive test of the SIDAM (Structured interview for the diagnosis of dementia of the Alzheimer type, multi-infarct dementia and dementias of other etiology according to ICD-10 and DSM-IV)]. 38
12491003 2002
170
Jian Nao Ning for treatment of memory impairment in patients with mild or moderate multi-infarct dementia. 38
16579082 2002
171
A case of primary cutaneous histoplasmosis in a patient with diabetes and multi-infarct dementia. 38
12532047 2002
172
A comparative study on the expression of cyclooxygenase and 5-lipoxygenase during cerebral ischemia in humans. 38
12410381 2002
173
Subcortical ischaemic vascular dementia. 38
12849365 2002
174
Interobserver variation in diagnosis of dementia by brain perfusion SPECT. 38
12553341 2002
175
Clinical Features of CADASIL. 38
12480760 2002
176
The complex nosological concept of vascular dementia. 38
12417348 2002
177
Mixed dementia--the most common cause of dementia. 38
12480742 2002
178
[Prevalence and incidence of dementia among nursing home residents and residents in homes for the aged in comparison to private homes]. 38
12395241 2002
179
-174 G/C interleukin-6 gene polymorphism and increased risk of multi-infarct dementia: a case-control study. 38
12086705 2002
180
[Hypertrophic cardiomyopathy: a rare cause of vascular dementia. A case report]. 38
12611354 2002
181
Psychiatric disorders among patients undergoing hemodialysis therapy. 38
12053079 2002
182
Vascular dementia revisited: diagnosis, pathogenesis, treatment, and prevention. 38
12168556 2002
183
Inositol monophosphatase activity in normal, Down syndrome and dementia of the Alzheimer type CSF. 38
11959401 2002
184
Co-morbidity associated with dementia. 38
11954672 2002
185
[Vascular dementias]. 38
11880947 2002
186
Cognitive impairment after stroke. 38
11796954 2002
187
[Adaptation of a dementia test for use in visually handicapped persons exemplified by SIDAM (Structured Interview for the Diagnosis of Alzheimer disease, Multi-Infarct Dementia and Dementias of other Etiology)]. 38
11974513 2002
188
[Vascular dementia]. 38
11925778 2002
189
Subcortical vascular dementia. 38
11901245 2002
190
Diagnosis and management of vascular cognitive impairment and dementia. 38
12597611 2002
191
[Binswanger's disease or multi-infarct dementia? Diagnostic keys in vascular dementia]. 38
11940426 2002
192
A comparison of scoring protocols on the Clock Drawing Test in relation to ease of use, diagnostic group, and correlations with Mini-Mental State Examination. 38
12028263 2002
193
Fibrinogen and the amount of leukoaraiosis in patients with symptomatic small-vessel disease. 38
12422065 2002
194
Increased blood-brain barrier permeability in white matter lesions of Binswanger's disease evaluated by contrast-enhanced MRI. 38
12053125 2002
195
Blood pressure variability and leukoaraiosis amount in cerebral small-vessel disease. 38
11903090 2001
196
Cognitive dysfunction and histological findings in adult rats one year after whole brain irradiation. 38
11803584 2001
197
Inflammatory markers in Alzheimer's disease and multi-infarct dementia. 38
11589916 2001
198
The factor structure in the cognitive battery of the structured interview for the diagnosis of dementia of the Alzheimer type, multi-infarct dementia, and dementias of other aetiology. 38
11768378 2001
199
[Clinical characteristics of subcortical arteriosclerotic encephalopathy (Binswanger's disease)]. 38
11433921 2001
200
White matter damage is associated with matrix metalloproteinases in vascular dementia. 38
11340226 2001
201
Both total and phosphorylated tau are increased in Alzheimer's disease. 9
11309456 2001
202
[Dementia and suicide]. 38
11386121 2001
203
A double dissociation between accuracy and time of execution on attentional tasks in Alzheimer's disease and multi-infarct dementia. 38
11287373 2001
204
[Reliability study of the Brazilian version of a structured interview for the diagnosis of dementia]. 38
11468677 2001
205
Increasing in situ nick end labeling of oligodendrocytes in white matter of patients with Binswanger's disease. 38
17903801 2001
206
Experience of ApoE study in Thai elderly. 38
11336076 2001
207
Blood pressure variability in Binswanger's disease and isolated lacunar infarction. 38
11306773 2001
208
Outcome of percutaneous endoscopic gastrostomy feeding in patients on peritoneal dialysis. 38
11510264 2001
209
Dementia in patients undergoing long-term dialysis: aetiology, differential diagnoses, epidemiology and management. 38
11580308 2001
210
Binswanger's disease is not a single entity. 38
11441570 2000
211
[Respiratory sleep disorders in the elderly]. 38
11140305 2000
212
Thrombin and antithrombin in Binswanger's disease. 38
11065234 2000
213
Perspectives in the treatment of vascular dementia. 38
12847569 2000
214
Vascular cell components of the medullary arteries in Binswanger's disease brains: a morphometric and immunoelectron microscopic study. 38
10926944 2000
215
A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia. 38
10867450 2000
216
[Binswanger disease: a common type of vascular dementia]. 38
10948585 2000
217
[Intravascular lymphomatosis: a rare etiology of recurrent cerebral ischemia]. 38
10935249 2000
218
Percutaneous treatment of peritrochanteric fractures using the Gamma nail. 38
10853151 2000
219
Recruitment procedures and their impact on the prevalence of dementia. Results from the Leipzig Longitudinal Study of the Aged (LEILA75+). 38
10705231 2000
220
A controlled study of vigabatrin and visual abnormalities. 38
10781514 2000
221
Blood pressure reduction and risk of dementia in patients with stroke: rationale of the dementia assessment in PROGRESS (Perindopril Protection Against Recurrent Stroke Study). PROGRESS Management Committee. 38
10939786 2000
222
Comparison between multiple lacunar infarcted patients with and without dementia in nursing homes in shimane prefecture, Japan. 38
10765047 2000
223
Glutamate uptake is decreased in platelets from Alzheimer's disease patients. 38
10805335 2000
224
[Neuropsychological pattern of cognitive impairment in Alzheimer type dementia and vascular dementia]. 38
10846674 2000
225
Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Is a focus on subcortical vascular dementia a solution? 38
10818515 2000
226
The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia. 38
10831772 2000
227
Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial. 38
10831773 2000
228
A promising approach to the treatment of multi-infarct dementia. 38
10867212 2000
229
[Improvement and application of multi-infarct dementia model in rats]. 38
11783311 2000
230
Amyloid precursor protein gene isoforms in Alzheimer's disease and other neurodegenerative disorders. 38
10675649 2000
231
Correlates of delayed referral for the diagnosis of dementia in an outpatient population. 38
10737692 2000
232
Cyclooxygenase-2 is induced in microglia during chronic cerebral ischemia in humans. 38
10651024 2000
233
Binswanger's disease: an ongoing controversy. 38
10956563 2000
234
Cerebral blood flow and glucose metabolism in multi-infarct-dementia related to primary antiphospholipid antibody syndrome. 38
10866105 2000
235
Research criteria for subcortical vascular dementia in clinical trials. 38
10961414 2000
236
[Vascular dementia]. 38
10791077 1999
237
Early-onset dementia in Lothian, Scotland: an analysis of clinical features and patterns of decline. 38
12811870 1999
238
Natural history of vascular dementia. 38
10609691 1999
239
Overlap between pathology of Alzheimer disease and vascular dementia. 38
10609690 1999
240
Personality change in dementia. 38
10547126 1999
241
Self-rated health assessment and development of both cardiovascular and dementing illnesses in an ambulatory elderly population: a report from the Bronx Longitudinal Aging Study. 38
11720624 1999
242
A study of platelet organelles and membrane glycoprotein in patients with Binswanger's disease. 38
11717951 1999
243
Magnetization transfer ratio in cerebral white matter lesions of Binswanger's disease. 38
10475100 1999
244
[Tomographic cerebral blood flow scanning in diagnosis of psychiatric disorders]. 38
10786251 1999
245
[Ginkgo biloba extract (EGb 761). State of knowledge in the dawn of the year 2000]. 38
10481350 1999
246
Vascular changes in white matter lesions of Alzheimer's disease. 38
10378382 1999
247
[A clinico-pathological and etiological study of Binswanger's Disease]. 38
11869523 1999
248
[Experimental study on multi-infarct dementia treated with reinforcing essence to refresh mental activity method]. 38
11783203 1999
249
Measuring the decline of a population of people with early-onset dementia in Lothian, Scotland. 38
10389038 1999
250
Partial characterization of apoptotic factor in Alzheimer plasma. 38
10198410 1999
251
[Hyperbaric oxygenation: a promising treatment for Binswanger's disease]. 38
10363299 1999
252
Change of tumor necrosis factor-alpha levels in patients with Binswanger's disease. 38
12899375 1999
253
Cerebral amyloid angiopathy with dementia: clinicopathological studies of 17 cases. 38
11593557 1999
254
From neuronal and vascular impairment to dementia. 38
10338104 1999
255
Circadian variation in blood pressure: implications for the elderly patient. 38
10090294 1999
256
Rheologic determinant changes of erythrocytes in Binswanger's disease. 38
10063717 1999
257
Increased coagulatory activity in subcortical arteriosclerotic encephalopathy (Binswanger's disease) 38
9987717 1999
258
[Binswanger's disease]. 38
10434697 1999
259
Do memory complaints indicate the presence of cognitive impairment? Results of a field study. 38
10449595 1999
260
Spectrum of disease in vascular cognitive impairment. 38
10461050 1999
261
[Prevalence, incidence, and risk factors of vascular dementia: the Hisayama study]. 38
10377799 1999
262
Cytopathological alterations and therapeutic approaches in Binswanger's disease. 38
19519655 1999
263
The effect of dehydroepiandrosterone sulfate administration to patients with multi-infarct dementia. 38
10064172 1999
264
Effects of antithrombin on Binswanger's disease with antiphospholipid antibody syndrome. 38
9932966 1999
265
Genetically determined vascular diseases. 38
10705639 1999
266
Vascular dementia today. 38
10637940 1999
267
[The role of immunologic reactions in the pathogenesis in Binswanger's disease; a clue to therapeutic approach]. 38
10377803 1999
268
[Binswanger's disease--diagnostic criteria and analysis of cases]. 38
11107574 1999
269
Pathophysiology of vascular dementia and white matter changes. 38
10528362 1999
270
Acetazolamide vasoreactivity in vascular dementia: a positron emission tomographic study. 38
9885326 1999
271
Racial differences in neuropsychiatric symptoms among dementia outpatients. 38
9919321 1999
272
Senile dementia of the Binswanger's type. 38
9861880 1998
273
The use of olfactory receptor neurons (ORNs) from biopsies to study changes in aging and neurodegenerative diseases. 38
9929674 1998
274
Prevalence of Alzheimer's disease and other dementing disorders: Assiut-Upper Egypt study. 38
9769445 1998
275
[Changes of erythrocyte and platelet membrane lipid pattern in different subtypes of dementia]. 38
11038832 1998
276
Indices of neuropsychological functioning and decline over time in dementia. 38
18653161 1998
277
Vasodilator responses to acetazolamide tested in subtypes of vascular dementia. 38
17895108 1998
278
Sensitivity and specificity of some neuropsychological markers of Alzheimer dementia. 38
9772017 1998
279
Giant cell arteritis complicated by multi-infarct dementia. 38
19078294 1998
280
Spiral maze performance in dementia. 38
9760667 1998
281
Spontaneity in dementia: an analysis of 696 institutionalized elderly patients. 38
9659818 1998
282
The validity of psychometric instruments for detection of dementia in the elderly general population. 38
9658272 1998
283
[Magnetization transfer imaging of periventricular white matter lesions in patients with multi-infarct dementia]. 38
9805986 1998
284
CADASIL: a review with proposed diagnostic criteria. 38
10210836 1998
285
Reliability of interview information in a family study in the elderly. 38
9540390 1998
286
Prevalence and disease associations of certain autoantibodies in elderly patients. 38
9512879 1998
287
[Vascular dementia--a concise concept?]. 38
9553222 1998
288
Binswanger's disease. A rare cause of dementia in elderly persons. 38
9591403 1998
289
Positron emission tomography in vascular dementia. 38
9543322 1998
290
CADASIL syndrome: a genetic form of vascular dementia. 38
9877528 1998
291
Effects of aging and dementia on the levels of thiobarbituric-acid-reactive products stimulated by L-glutamic acid in human autopsy and biopsy brain tissue. 38
9469258 1998
292
A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality. 38
9436725 1998
293
Propentofylline in the treatment of vascular dementia and Alzheimer-type dementia: overview of phase I and phase II clinical trials. 38
9769027 1998
294
Ginkgo biloba and Memory: An Overview. 38
27414695 1998
295
[PERCUTANEOUS ENCOSCOPIC GASTROSTOMY] 38
12271336 1998
296
Blood-brain barrier dysfunction in Binswanger's disease; an immunohistochemical study. 38
9452825 1998
297
Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases. 38
9409393 1997
298
Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases. 38
9409394 1997
299
Giant cell (temporal) arteritis. 38
9367971 1997
300
Classification, diagnosis and treatment of vascular dementia. 38
9359023 1997
301
[Survival of patients with dementia in an Icelandic daycare center.]. 38
19679909 1997
302
Magnetic resonance imaging of the ageing brain. 38
9529750 1997
303
A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. 38
9343463 1997
304
Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. 38
9339696 1997
305
[Binswanger's disease: clinicopathological study of a case]. 38
9629419 1997
306
Excitatory pattern of gamma-interferon on natural killer cell activity in senile dementia of the Alzheimer type. 38
9298632 1997
307
Serum protein leakage in Alzheimer's disease revisited. 38
9329689 1997
308
Is positron emission tomography useful in stroke? 38
9345587 1997
309
[The significance of leukoaraiosis. A current evaluation and differential diagnosis]. 38
9380205 1997
310
Profiles of cognitive functioning in subjects with neurological disorders. 38
9220363 1997
311
Neurological signs and frontal white matter lesions in vascular parkinsonism. A clinicopathologic study. 38
9158634 1997
312
Regional atrophy of the corpus callosum in subjects with Alzheimer's disease and multi-infarct dementia. 38
9204509 1997
313
[Frontal-subcortical neuronal circuits]. 38
9235314 1997
314
Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. 38
9110101 1997
315
Widespread dilatation of perivascular spaces: a leukoencephalopathy causing dementia. 38
9153463 1997
316
Geriatrics photo quiz. Multi-infarct dementia. 38
9152214 1997
317
[Clinico-pathological correlation in the main types of dementia]. 38
9172915 1997
318
The angiopathy of subcortical arteriosclerotic encephalopathy (Binswanger's disease): immunohistochemical studies using markers for components of extracellular matrix, smooth muscle actin and endothelial cells. 38
9083552 1997
319
The NUH Memory Clinic. National University Hospital, Singapore. 38
9269377 1997
320
[Epidemiologic autopsy of Binswanger's disease]. 38
9172451 1997
321
Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases. 38
9065545 1997
322
Suicidal thinking in community residents over eighty. 38
9152718 1997
323
Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. 38
23195239 1997
324
[CADASIL: 2 case reports of hereditary multi-infarct dementia]. 38
9157051 1997
325
Auditory P300, CT scans and cognitive state in Binswanger's disease. 38
9170551 1997
326
[A case of Sjögren's syndrome with a high titer of anticardiolipin antibody that developed as parkinsonism]. 38
9146077 1997
327
[Clinical characteristics and trends in research of Parkinson's disease and parkinsonism in Japan]. 38
9014416 1997
328
Neurochemical differences in the CSF between Binswanger's and Alzheimer's disease. 38
8997550 1997
329
Vascular dementia: challenge of clinical diagnosis. 38
9447427 1997
330
Different manifestations of circadian rhythms in senile dementia of Alzheimer's type and multi-infarct dementia. 38
8983038 1997
331
[Vascular parkinsonism]. 38
9014431 1997
332
A multicenter randomized double-blind study on the efficacy and safety of nicergoline in patients with multi-infarct dementia. 38
8997547 1997
333
Somatostatin, its molecular forms and monoaminergic transmitter metabolites in Binswanger's disease. Neurochemical-neuropathological considerations. 38
9117548 1996
334
The apolipoprotein E gene in Binswanger's disease and vascular dementia. 38
9147873 1996
335
Eosinophilic bodies in the cerebral cortex of Alzheimer's disease cases. 38
8960312 1996
336
[A 91-year-old man with a stroke, hypertension, and renal failure]. 38
8990484 1996
337
Vascular dementia: still a debatable entity? 38
8981295 1996
338
[Lipoprotein (a) and plasminogen in atherosclerosis]. 38
9011833 1996
339
Binding of platelet-activating factor to platelets of Alzheimer's disease and multiinfarct dementia patients. 38
9363797 1996
340
Favorable effect of transcranial electrostimulation on behavior disorders in elderly patients with dementia: a double-blind study. 38
9003961 1996
341
Prevalence of dementia and its subtypes in the Japanese American population of King County, Washington state. The Kame Project. 38
8857825 1996
342
[Clinico-pathological evaluation of leukoaraisosis in Alzheimer's disease]. 38
8958737 1996
343
[Diffusional anisotropy in cerebral white matter in patients with dementia]. 38
8958739 1996
344
The first Italian report on "Binswanger's disease". 38
8933231 1996
345
Expression of CAP37, a novel inflammatory mediator, in Alzheimer's disease. 38
8892348 1996
346
The role of endothelin-1 in Binswanger's disease. 38
8940785 1996
347
From UBOs to Binswanger's disease. Impact of magnetic resonance imaging on vascular dementia research. 38
8711785 1996
348
Atrophy of hippocampus in patients with Alzheimer's disease and other diseases with memory impairment. 38
8835880 1996
349
Language comprehension profiles in Alzheimer's disease, multi-infarct dementia, and frontotemporal degeneration. 38
8710075 1996
350
Risk of mortality and institutionalization in demented patients with delusions. 38
8873875 1996
351
[Clinical and instrumental diagnosis of Alzheimer's and multi-infarct dementia]. 38
8966268 1996
352
White matter disease and dementia. 38
8812003 1996
353
Neuropsychological aspects of vascular dementia. 38
8812007 1996
354
On the EEG component waves of multi-infarct dementia seniles. 38
8828064 1996
355
Patterns of neuropsychological impairment in dementia of the Alzheimer type and multi-infarct dementia. 38
15374164 1996
356
Validity of the family history method in relatives of gerontopsychiatric patients. 38
8804133 1996
357
[Clinical aspects and pathogenetic mechanisms of cognitive impairment in arterial hypertension]. 38
8927259 1996
358
Differences in dexamethasone-sensitivity between lymphocytes from patients with Alzheimer's disease and patients with multi-infarct dementia. 38
8811935 1996
359
[Regional cerebral blood flow and periventricular hyperintensity in silent cerebral infarction--comparison with multi-infarct dementia]. 38
8937195 1996
360
Brain failure in older patients. Uncovering treatable causes of a diminished ability to think. 38
8650080 1996
361
[Correlation between periventricular lucency and extracranial arterial lesions]. 38
8741369 1996
362
Left ventricular hypertrophy on electrocardiogram: prognostic implications from a 10-year cohort study of older subjects: a report from the Bronx Longitudinal Aging Study. 38
8617900 1996
363
Amino acid concentration in dementia of the Alzheimer type and multi-infarct dementia. 38
8726221 1996
364
[Image analysis in patients with dementia]. 38
8752524 1996
365
Quantified-EEG in normal aging and dementias. 38
8800344 1996
366
Aspirin use and cognitive function in the elderly. 38
8651230 1996
367
[Diffusion MRI study of cerebral white matter lesions in patients with Binswanger's disease]. 38
8741347 1996
368
Comparative study of aprosody in Alzheimer's disease and in multi-infarct dementia. 38
8866676 1996
369
Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. 38
8741021 1996
370
The role of autoimmunity in vascular dementia. 38
8866682 1996
371
Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. 38
8618665 1996
372
Pupillary response to topical tropicamide as a marker for Alzheimer's disease. 38
8866930 1996
373
[Problems in vascular dementia]. 38
8648889 1996
374
[Lipid metabolism parameters in patients with multi-infarct dementia and Alzheimer's type dementia]. 38
8756248 1996
375
A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis. 38
8630963 1996
376
[A 83 year-old woman with dementia, gait disturbance, and convulsion]. 38
9046533 1996
377
The Mini-Mental State Examination in Alzheimer's disease and multi-infarct dementia. 38
8805093 1996
378
Visual and somatosensory evoked potentials in Parkinson's and Binswanger's disease. 38
8788083 1996
379
Antiphospholipid antibodies and Binswanger's disease. 38
8559412 1996
380
Antiphospholipid antibodies and Binswanger's disease. 38
8559413 1996
381
Longitudinal changes in cognitive functioning in adult day care participants. 38
8679061 1996
382
Therapeutic efficacy of vincamine in dementia. 38
8884757 1996
383
Senile dementia of Alzheimer type and multi-infarct dementia investigated by transcranial Doppler sonography. 38
8788081 1996
384
[Closing-in phenomena observed in patients with Alzheimer's disease--analysis of drawing behavior and eye movements]. 38
8710992 1996
385
European Pentoxifylline Multi-Infarct Dementia Study. 38
8864715 1996
386
Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex. 38
8717605 1996
387
Multimodal evoked potentials in Alzheimer's disease and Binswanger's disease. 38
8679063 1996
388
Patterns of neuropsychological impairment in mild dementia: a comparison between Alzheimer's disease and multi-infarct dementia. 38
8750107 1995
389
[Neuro-specific enolase in acute ischemic stroke and related dementia patients]. 38
9208570 1995
390
Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders. 38
8601054 1995
391
Assessing vascular dementia. 38
8538823 1995
392
[Difference in MRI findings and risk factors between multiple infarction without dementia and multi-infarct dementia]. 38
7499460 1995
393
Review: Binswanger's disease, leukoaraiosis and dementia. 38
8669355 1995
394
Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type. 38
7545739 1995
395
[Subtype identification in vascular dementia. An important step towards more precise diagnosis and improved treatment]. 38
7674714 1995
396
Patterns of functional damage in neural network models of associative memory. 38
7584889 1995
397
[Binswanger's disease: evolution of thought and a proposed diagnostic triad]. 38
8540834 1995
398
[A case of Binswanger's disease in which an acute infarcted lesion was detected by diffusion-weighted magnetic resonance imaging]. 38
7500555 1995
399
The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review. 38
7604429 1995
400
Clinical classification of dementias. 38
15374218 1995
401
High-resolution SPECT to assess hippocampal perfusion in neuropsychiatric diseases. 38
7790939 1995
402
SPECT perfusion imaging in the diagnosis of dementia. 38
7626837 1995
403
Importance of platelet functions in Alzheimer's disease. 38
15374225 1995
404
Binswanger's disease presenting as levodopa-responsive parkinsonism: clinicopathologic study of three cases. 38
7565825 1995
405
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)--confirmation by cerebral biopsy in 2 cases. 38
8521622 1995
406
The prevalence of dementia and depression in the elderly community in a southern European population. The Zaragoza study. 38
7771920 1995
407
Variability in scoring the Hachinski Ischaemic Score. 38
7645446 1995
408
Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease. 38
7605102 1995
409
Alzheimer and vascular dementias and driving. A prospective road and laboratory study. 38
7715061 1995
410
Electroencephalography and single photon emission computed tomography in dementia: a comparative study. 38
7480442 1995
411
Energy requirements in Alzheimer's disease patients. 38
8541694 1995
412
Cortical Lewy bodies in Alzheimer's disease. 38
7748074 1995
413
A qualitative analysis of semantic intrusive errors in Alzheimer's disease. 38
14588692 1995
414
Severity of dementia correlates with loss of broad-band visual cortical responses. 38
7620530 1995
415
Depressive symptoms in Alzheimer's disease and multi-infarct dementia. 38
7794481 1995
416
Delusions and dementia: clinical and CT correlates. 38
7625153 1995
417
Binswanger's disease--revisited. 38
7723946 1995
418
Prevalence of senile dementia in Okinawa, Japan. COSEPO Group. Study Group of Epidemiology for Psychiatry in Okinawa. 38
7635599 1995
419
Influence of aging and neurodegenerative disease on changes in band 3-like proteins in white blood cells. 38
7564560 1995
420
The efficiency of CAMDEX in the diagnosis of dementia and its sub-types. 38
7756011 1995
421
Strategic infarcts in vascular dementia. A clinical and brain imaging experience. 38
7763329 1995
422
(3H)hemicholinium-3 binding sites in postmortem brains of human patients with Alzheimer's disease and multi-infarct dementia. 38
8591807 1995
423
Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia. 38
7793228 1995
424
Design fluency in dementia of Alzheimer's type, multi-infarct dementia and dementia associated with alcoholism. 38
16318546 1995
425
Nonspecific leukoencephalopathy associated with aging. 38
7743083 1995
426
Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study. 38
7604138 1995
427
Computed tomography in the detection of the vascular component in dementia. 38
7744267 1995
428
[Binswanger's disease and the problem of vascular dementia: on the centenary of its first description]. 38
7778405 1995
429
Binswanger's disease : no longer a rare entity. 38
29542475 1995
430
The older patient with psychotic symptoms. 38
7895123 1995
431
Psychiatric symptomatology in early-onset Binswanger's disease: two case reports. 38
24487402 1995
432
Platelet activation in the cerebral circulation in different subtypes of ischemic stroke and Binswanger's disease. 38
7839397 1995
433
Patterns of neuropsychological functioning among patients with multi-infarct and Alzheimer's dementia: a comparative analysis. 38
8821347 1995
434
Prevalence of dementia among elderly Chinese and Malay residents of Singapore. 38
8821351 1995
435
What provision is made by practicing physicians for psychogeriatric patients in western Germany? 38
7579014 1995
436
Survival and dementia: a 7-year follow-up of an Italian elderly population. 38
15374264 1995
437
Beta activity in aging and dementia. 38
8793127 1995
438
Familial young-adult-onset arteriosclerotic leukoencephalopathy with alopecia and lumbago without arterial hypertension. 38
7796840 1995
439
Hereditary multi-infarct dementia unlinked to chromosome 19q12 in a large Scottish pedigree: evidence of probable locus heterogeneity. 38
7897629 1995
440
Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease. 38
7700527 1995
441
[Magnetic resonance imaging in vascular dementia]. 38
8543901 1995
442
[Morphological imaging in the diagnosis of dementia. II. Vascular dementia]. 38
7740230 1995
443
Relationships between EEG coherence and neuropsychological tests in dementia. 38
7882542 1995
444
[Rest-activity and body-temperature rhythm disorders in elderly patients with dementia--senile dementia of Alzheimer's type and multi-infarct dementia]. 38
7781209 1995
445
Psychopathology and cognitive decline in dementia. 38
7989914 1994
446
Differential diagnosis of dementia, delirium and depression. Implications for drug therapy. 38
7858369 1994
447
Pathogenic factors underlying the lesions in Leigh's disease. Tissue responses to cellular energy deprivation and their clinico-pathological consequences. 38
7820572 1994
448
A Scottish record linkage study of risk factors in medical history and dementia outcome in hospital patients. 38
7866488 1994
449
Comparative immunohistochemical characteristics of human choroid plexus in vascular and Alzheimer's dementia. 38
7959663 1994
450
Effect of white matter disease on functional connections in the aging brain. 38
7964810 1994
451
Multi-infarct dementia (MID). 38
7853857 1994
452
[Binswanger disease. A blood pressure-related dementia]. 38
7808149 1994
453
p(C) analysis facilitates dementia diagnosis. 38
7808214 1994
454
Neurophysiology and SPECT cerebral blood flow patterns in dementia. 38
7522145 1994
455
The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT). 38
7994501 1994
456
[Binswanger's disease and its relationship with vascular risk factors]. 38
7984792 1994
457
Psychiatric symptoms in dementia associated with stroke: a case-control analysis among predominantly African-American patients. 38
7966434 1994
458
[Binswanger's disease]. 38
7984791 1994
459
[The role of platelet in the etiology of Binswanger's disease]. 38
7823402 1994
460
The discriminant value of semiquantitative SPECT data in mild Alzheimer's disease. 38
8071690 1994
461
Epidemiological survey of dementia and depression among the aged living in the community in Japan. 38
7891413 1994
462
The ageing of elderly people. 38
7899898 1994
463
beta-Amyloid protein immunoreactivity in skin is not a reliable marker of Alzheimer's disease. An autopsy-controlled study. 38
8042928 1994
464
[Clinical study of platelet activation in cerebral circulation--comparison between ischemic stroke subtypes and Binswanger's disease]. 38
7994986 1994
465
Models for central nervous system complications of antiphospholipid syndrome. 38
7804311 1994
466
Motor apraxia in dementia. 38
7528910 1994
467
Quantitative EEG Correlates of Outcome in Older Psychiatric Patients: Part I: Cross-Sectional and Longitudinal Assessment of Patients With Dementia. 38
28530933 1994
468
Neuroendocrine studies in dementia patients: responses of plasma GH and PRL following bromocriptine administration. 38
7941955 1994
469
A young case with multi-infarct dementia associated with lupus anticoagulant. 38
7919628 1994
470
The value of HMPAO SPECT scanning in the diagnosis of early Alzheimer's disease in patients attending a memory clinic. 38
8078635 1994
471
Dementia among the elderly in a rural Korean community. 38
7952986 1994
472
Reduced EEG coherence in dementia: state or trait marker? 38
8054410 1994
473
Risk factors for vascular dementia: a review. 38
8087168 1994
474
The clinical diagnosis of vascular dementia. 38
8087176 1994
475
The ICD-10 criteria for vascular dementia. 38
8087177 1994
476
Multi-infarct dementia. 38
8027633 1994
477
The neurochemistry of vascular dementia. 38
8087172 1994
478
SPECT for differential diagnosis of dementia and correlation of rCBF with cognitive impairment. 38
8087734 1994
479
An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. 38
8190290 1994
480
[Level of vitamin B12 and folic acid in blood serum of patients with senile dementia]. 38
7817592 1994
481
White matter changes: neurobehavioral manifestations of Binswanger's disease and clinical correlates in Alzheimer's disease. 38
8087170 1994
482
[A study on the relation between cerebral lesion and cognitive defect in multi-infarct patients]. 38
7835145 1994
483
Vascular subcortical dementias: clinical aspects. 38
8087175 1994
484
A multi-institutional study of interobserver agreement in the evaluation of dementia with rCBF/SPET technetium-99m exametazime (HMPAO). 38
8005154 1994
485
[Three-dimensional surface display with 123I-IMP brain perfusion imaging in patients with dementia]. 38
8026123 1994
486
Multi-infarct dementia in Down's syndrome. 38
8193456 1994
487
[Emotional components of language in multi-infarct dementia]. 38
8208023 1994
488
Electroencephalography as an aid in the exclusion of Alzheimer's disease. 38
8129640 1994
489
The Gospel Oak Study stage III: the incidence of dementia. 38
8208898 1994
490
Serum alpha 1-antitrypsin and alpha 2-macroglobulin in Alzheimer's and Binswanger's disease. 38
7516751 1994
491
Verbal and spatial memory spans in Alzheimer's and multi-infarct dementia. 38
8191876 1994
492
Parkinson's disease, ischemic stroke, dementia, and cranial computed tomography: Preliminary study. 38
26487606 1994
493
Differential diagnosis of dementia: a prospective evaluation of the DAT Inventory. 38
8277109 1994
494
Results of a two-month follow-up after single heparin-induced extracorporeal LDL precipitation in vascular dementia. 38
26486057 1994
495
Bundles of amyloid precursor protein-immunoreactive axons in human cerebrovascular white matter lesions. 38
8059597 1994
496
A long-term follow-up study of cerebrospinal fluid 5-hydroxyindoleacetic acid in delirium. 38
7528542 1994
497
Serum tumor necrosis factor (TNF) in Alzheimer's disease and multi-infarct dementia. 38
8164471 1994
498
Cytosolic free [Ca2+] in mononuclear blood cells from demented patients and healthy controls. 38
8172935 1994
499
Risk factors for Alzheimer's disease and dementia: a case-control study based on the MRC elderly hypertension trial. 38
8290099 1994
500
Agreement in the clinical diagnosis of dementia: evaluation of a case series with mild cognitive impairment. 38
8015668 1994
501
Screening schizophrenic patients for mutations in the amyloid precursor protein gene. 38
8049900 1994
502
Opportunities and challenges in international collaborative epidemiologic research of dementia and its subtypes: studies between Japan and the U.S. 38
7865708 1994
503
Expression of small heat-shock protein hsp 27 in reactive gliosis in Alzheimer disease and other types of dementia. 38
8059604 1994
504
Pathogenetic mechanisms in vascular dementia. 38
8180420 1994
505
Reliability and validity of the Hierarchic Dementia Scale. 38
8054498 1994
506
[Clinical differences in senile dementia of the Alzheimer's type and in multi-infarct dementia]. 38
8009931 1994
507
Review: Binswanger's disease, leukoaraiosis and dementia. 38
8010178 1994
508
Small arterial granular degeneration in familial Binswanger's syndrome. 38
8140899 1994
509
[Multimodal evoked potentials in patients with dementia]. 38
8114343 1993
510
Polycythaemia vera and cerebral blood flow: a preliminary study with transcranial Doppler. 38
7903108 1993
511
[Binswanger disease. Tomographic picture and clinical correlations]. 38
8306573 1993
512
[Cerebral blood flow and metabolism in multi-infarct dementia by positron emission tomography]. 38
8121035 1993
513
[Auditory middle latency responses (MLRs) in patients with multi-infarct dementia (MID)]. 38
8121037 1993
514
[Neuropathological and clinical aspects of Binswanger's disease, vascular dementia of Binswanger type]. 38
8121028 1993
515
An autopsy case of Binswanger's disease without hypertension and associated with cerebral infarction in the terminal stage. 38
8201801 1993
516
Regional differences in brain electrical activity in dementia: use of spectral power and spectral ratio measures. 38
7508371 1993
517
The Cerebral Circulation in the Elderly: The Influence of Age, Vascular Disease, and Antihypertensive Treatment. 38
11416298 1993
518
Differential rates of forgetting from long-term memory in Alzheimer's and multi-infarct dementia. 38
8132410 1993
519
Single photon emission computerised tomography in elderly patients with Alzheimer's disease and multi-infarct dementia. Regional uptake of technetium-labelled HMPAO related to clinical measurements. 38
8298827 1993
520
Relationship of interleukin-1 beta and beta 2-microglobulin with neuropeptides in cerebrospinal fluid of patients with dementia of the Alzheimer type. 38
7693756 1993
521
Geropsychology and neuropsychological testing: role in evaluation and treatment of patients with dementia. 38
8121430 1993
522
Clinical evaluation of dementia. 38
8121431 1993
523
Psychopathology associated with Alzheimer's disease and related disorders. 38
8227995 1993
524
Neurologic aspects of giant cell (temporal) arteritis. 38
8265830 1993
525
Convex third ventricle: a possible sign for dementia using MRI. 38
8251050 1993
526
[Hemorrheology and quality of life in fibrinogen- and lipid-lowering therapy]. 38
8211041 1993
527
Failure of CT scan to detect ischemic lesions in patients with dementia. 38
8251055 1993
528
A quantitative review of the diagnostic utility of the WAIS-R Fuld profile. 38
14589711 1993
529
[Heparin-induced extracorporeal LDL precipitation (HELP). A new therapeutic possibility in cerebral multi-infarct dementia]. 38
8232678 1993
530
Improved neurological recovery of cerebral infarctions after plasmapheretic reduction of lipids and fibrinogen. 38
8378944 1993
531
[Progressive encephalopathy in antiphospholipid antibody syndrome]. 38
8248057 1993
532
Sensitivity and specificity of 99Tcm-HMPAO single-headed SPECT in dementia. 38
8233245 1993
533
Horizontal component of electro-oculogram as a parameter of arousal in dementia: relationship between intellectual improvement and increasing arousal under pharmacotherapy. 38
8408736 1993
534
Chronic obstructive pulmonary disease. An original model of cognitive decline. 38
8342906 1993
535
Delusions in Alzheimer's disease and multi-infarct dementia. 38
8372630 1993
536
[Factors for weight loss in patients with senile dementia]. 38
8361078 1993
537
Heterogeneity of vascular dementia: mechanisms and subgroups. 38
8397762 1993
538
Hemineglect and seizures in Binswanger's disease: clinical-pathological report. 38
8331360 1993
539
Blood pressure and cognitive function in healthy old people. 38
8315187 1993
540
Risk factors for dementia associated with multiple cerebral infarcts. A case-control analysis in predominantly African-American hospital-based patients. 38
8323474 1993
541
Neuropsychological test patterns in men for Alzheimer's and multi-infarct dementia. 38
14589663 1993
542
Single photon emission computed tomography in dementia: relationship of perfusion to cognitive deficits. 38
8397758 1993
543
EEG power spectra and cognitive change in geriatric psychiatry: a longitudinal study. 38
7686470 1993
544
Diagnosis of multi-infarct dementia: predictive value of clinical criteria. 38
8321588 1993
545
The value of transcranial Doppler sonography in the differential diagnosis of Alzheimer disease vs multi-infarct dementia. 38
8363702 1993
546
Hypouricemia, abnormal renal tubular urate transport, and plasma natriuretic factor(s) in patients with Alzheimer's disease. 38
8486882 1993
547
[Reduction of drug intake following admission to a psychogeriatric nursing home: discontinuation is possible]. 38
8506001 1993
548
Drug use patterns of persons with Alzheimer's disease and related disorders living in the community. 38
8463528 1993
549
A comparative I-123 IMP SPECT study in Binswanger's disease and Alzheimer's disease. 38
8482030 1993
550
Transcranial Doppler ultrasonography in senile dementia: neuropsychological correlations. 38
8332036 1993
551
Epidemiology of Alzheimer's presenile dementia in Scotland, 1974-88. 38
8471918 1993
552
Multimodal evoked potentials in Binswanger's disease and Alzheimer's disease. 38
8083006 1993
553
Occurrence of paroxysmal synchronous EEG discharges in subcortical arteriosclerotic encephalopathy (Binswanger's disease). 38
8329820 1993
554
Gait disorders of multi-infarct dementia. CT and clinical correlation. 38
8475697 1993
555
Resting energy expenditure in relation to energy intake in patients with Alzheimer's disease, multi-infarct dementia and in control women. 38
8470560 1993
556
Correlations of leuko-araiosis with cerebral atrophy and perfusion in elderly normal subjects and demented patients. 38
8437007 1993
557
Differentiation of multi-infarct and Alzheimer dementia by intracranial hemodynamic parameters. 38
8421824 1993
558
Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study. 38
8471678 1993
559
Clinical aspects of nimodipine. 38
8519001 1993
560
Multichannel EEG frequency analysis and somatosensory-evoked potentials in patients with different types of organic dementia. 38
8358505 1993
561
Circulating immune complexes in sera from patients with Alzheimer's disease and subjects with age-associated memory impairment. 38
8123191 1993
562
Binswanger's disease. 38
8517210 1993
563
How to run a brain bank: potentials and pitfalls in the use of human post-mortem brain material in research. 38
8360663 1993
564
CSF cholinesterase in early-onset and late-onset Alzheimer's disease and multi-infarct dementia of Chinese patients. 38
8424308 1993
565
Responders and non-responders to bifemelane hydrochloride in Alzheimer-type and multi-infarct dementia. 38
8345159 1993
566
Differences in erythrocyte aggregability between multi-infarct dementia and Alzheimer's disease. 38
26487254 1993
567
Circulating immune complexes in sera from patients with Alzheimer's disease, multi-infarct dementia and Down's syndrome. 38
8469384 1993
568
Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study. 38
8418535 1993
569
Clinical evaluation of the ICD-10 criteria for vascular dementia. 38
8399408 1993
570
A population-based study of dementia in 85-year-olds. 38
8417380 1993
571
[Clinical diagnosis of Biswanger's disease]. 38
8465024 1993
572
Neuronal thread protein over-expression in brains with Alzheimer's disease lesions. 38
1487753 1992
573
Dementia in old age. 38
1345158 1992
574
[Application of ischemic score of Hachinski in differentiation of multi-infarct dementia]. 38
1304994 1992
575
Randomized, double-blind, placebo controlled, multicentre study of idebenone in patients suffering from multi-infarct dementia. 38
15374363 1992
576
Idebenone in the treatment of multi-infarct dementia: a randomised, double-blind, placebo controlled multicentre trial. 38
15374366 1992
577
Are thrombocyte membranes altered in Alzheimer's disease? A morphometric and biochemical study. 38
1491736 1992
578
[Cerebrovascular CO2 reactivity in patients with dementia due to multiple infarction in the territory of the perforating artery]. 38
1301322 1992
579
Regional cerebral blood flow measured with I-123 IMP SPECT in a case of subcortical arteriosclerotic encephalopathy (Binswanger's disease). 38
1424377 1992
580
Long-term idebenone treatment of vascular and degenerative brain disorders of the elderly. 38
15374365 1992
581
Serum histamine in Alzheimer's disease and multi-infarct dementia. 38
1294859 1992
582
[Multi-infarct dementia in nursing home patients; more comorbidity and shorter life expectancy than in Alzheimer's disease]. 38
1436202 1992
583
Dementia in cerebral amyloid angiopathy: a clinicopathological study. 38
1447572 1992
584
[Later onset metachromatic leukodystrophy diagnosed by nerve biopsy]. 38
1337886 1992
585
Changes in brain functional connectivity in Alzheimer-type and multi-infarct dementia. 38
1422803 1992
586
Neuropathologic findings in multi-infarct dementia associated with anticardiolipin antibody. Evidence for endothelial injury as the primary event. 38
1418019 1992
587
An autopsied case of interferon encephalopathy. 38
1487856 1992
588
[Demonstration of cardiac arrhythmias in multi-infarct dementia and ischemic stroke using Holter monitoring]. 38
1291897 1992
589
Binswanger's disease and German translations. 38
1524510 1992
590
Serial visual evoked potential recordings in geriatric psychiatry. 38
1378002 1992
591
Subclinical dementia: relevance of cognitive symptoms and signs. 38
1497794 1992
592
Toward a definite diagnosis of Alzheimer's disease. 38
1643871 1992
593
No evidence for reduced thrombocyte cytochrome oxidase activity in Alzheimer's disease. 38
1318523 1992
594
Assessment of cognitive, psychiatric, and behavioral disturbances in patients with dementia: the Neurobehavioral Rating Scale. 38
1587970 1992
595
Cranial computed tomographic observations in multi-infarct dementia. A controlled study. 38
1595096 1992
596
Antiphospholipid antibody syndrome: a case study. 38
1645036 1992
597
[A preliminary study of cerebrospinal fluid cytology in aged patients with dementia]. 38
1395943 1992
598
Fluvoxamine in the treatment of demented elderly patients: a double-blind, placebo-controlled study. 38
1642129 1992
599
[Use of 99mTc-HMPAO SPECT in the study of AIDS-correlated dementia]. 38
1496187 1992
600
[Transitional objects as regression phenomena in demented patients]. 38
1603187 1992
601
Amyloid beta protein precursors with kunitz-type inhibitor domains and acetylcholinesterase in cerebrospinal fluid from patients with dementia of the Alzheimer type. 38
1377855 1992
602
Marked increase in cerebrospinal fluid ubiquitin in Creutzfeldt-Jakob disease. 38
1328965 1992
603
Sensitivity and specificity of death certificate diagnoses for dementing illnesses, 1988-1990. 38
1634701 1992
604
Hypertension and the brain. The National High Blood Pressure Education Program. 38
1580719 1992
605
Memory failure in binswanger's disease and alzheimer's disease. 38
29022447 1992
606
Vitamin B12 in CSF: reduced CSF/serum B12 ratio in demented men. 38
1585799 1992
607
[Contributing factors to intellectual impairment in patients with multiple lacunar infarctions]. 38
1614010 1992
608
Prevalence of moderate and severe Alzheimer dementia and multi-infarct dementia in the population of southeastern Sicily. 38
1624277 1992
609
The nature of excess mortality in nursing home patients with dementia. 38
1538062 1992
610
Glial fibrillary acidic protein stimulates proliferation and immunoglobulin synthesis of lymphocytes from Alzheimer's disease patients. 38
1598026 1992
611
Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease. 38
1564478 1992
612
Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease. 38
1575097 1992
613
Pentoxifylline in cerebrovascular dementia. 38
1538042 1992
614
Slowly progressive familial dementia with recurrent strokes and white matter hypodensities on CT scan. 38
1592574 1992
615
Post-mortem proton magnetic resonance spectrometric measures of brain regions in patients with a pathological diagnosis of Alzheimer's disease and multi-infarct dementia. 38
1540758 1992
616
Granulovacuolar degeneration in the hippocampal cortex of aging and demented patients--a quantitative study. 38
1285490 1992
617
Single-photon emission computerized tomography (SPECT) in neuropsychiatry: a review. 38
24487738 1992
618
Twenty-four-hour beta-endorphin secretory pattern in Alzheimer's disease. 38
1454159 1992
619
HELP application in multi-infarct dementia. 38
26486840 1992
620
Treatment of multi-infarct dementia with citicholine. 38
26486841 1992
621
Hypertension and vascular dementia. 38
1739272 1992
622
Disturbance in cerebrovascular CO2 reactivity in multi-infarct dementia. 38
26486843 1992
623
DSM-III-R criteria for primary degenerative dementia and multi-infarct dementia [corrected]. 38
1389080 1992
624
[Hemorheology and H.E.L.P. in multi-infarct dementia]. 38
1534954 1992
625
Moving from the question of efficacy to the question of therapeutic relevance: an exploratory reanalysis of a controlled clinical study of 130 inpatients with dementia syndrome taking piracetam. 38
1391670 1992
626
Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia. 38
1613816 1992
627
Clinical research on treating senile dementia by combining acupuncture with acupoint-injection. 38
1353652 1992
628
Prolongation of magnetic resonance T2 time in hippocampus of human patients marks the presence and severity of Alzheimer's disease. 38
1589144 1992
629
Survival in presenile Alzheimer's and multi-infarct dementias. 38
1407247 1992
630
A new systematic method of measurement and diagnosis of "mild cognitive impairment" and dementia according to ICD-10 and DSM-III-R criteria. 38
1288663 1992
631
Alzheimer and Kraepelin describe Binswanger's disease. 38
1627963 1992
632
[Multi-infarct and Alzheimer dementia--problems of differential diagnosis]. 38
1584957 1992
633
Rating scales and computed tomography in multi-infarct dementia. 38
1463803 1992
634
Vascular dementia: a clinical and death certificate study. 38
1495574 1992
635
Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID). 38
1475039 1992
636
Clinical studies with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia of mild to moderate degree. 38
1603291 1992
637
Comparison of quantitative magnetic resonance imaging and positron emission tomography between patients with dementia of the alzheimer type and multi-infarct dementia. 38
26486837 1992
638
Binswanger's disease in the absence of chronic arterial hypertension. A case report with clinical, radiological and immunohistochemical observations on intracerebral blood vessels. 38
1575021 1992
639
[Clinical and differential diagnosis of multi-infarct dementia and Alzheimer's disease]. 38
1528370 1992
640
Treatment of chronic cerebrovascular disease in elderly patients with pentoxifylline. 38
1293252 1992
641
Circadian rhythm disorders in sleep-waking and body temperature in elderly patients with dementia and their treatment. 38
1798879 1991
642
Binswanger's clinical and neuropathological criteria for "Binswanger's disease". 38
1783935 1991
643
[Cerebral vascular damage in hypertension]. 38
1841789 1991
644
[Binswanger's disease with normal pressure hydrocephalus. Case report]. 38
1726234 1991
645
Binswanger's disease and normal-pressure hydrocephalus. Clinical and neuropsychological comparison. 38
1953401 1991
646
[Multi-infarct dementia in giant cell arteritis (temporal arteritis)]. 38
1766283 1991
647
Lacunar infarctions due to cholesterol emboli. 38
1750055 1991
648
Clinical use of CT and MR scans in psychiatric patients. 38
1786261 1991
649
Differences between multi-infarct dementia and Alzheimer's disease on unstructured neuropsychological tasks. 38
1779031 1991
650
Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia. 38
1835658 1991
651
Sleep-wake cycles in multi-infarct dementia and dementia of the Alzheimer type. 38
1922804 1991
652
[Demyelinating elements of demyelinated encephalopathy]. 38
1684319 1991
653
99Tcm-HMPAO SPECT in suspected dementia. 38
1945187 1991
654
Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disorders. 38
1784142 1991
655
The generalizability of training gains in dementia: effects of an imagery-based mnemonic on face-name retention duration. 38
1930767 1991
656
Cholinergic grafts, memory and ageing. 38
1721745 1991
657
Increased cytosolic free calcium in lymphocytes of Alzheimer patients. 38
1829731 1991
658
Treatment considerations for the hypertensive patient over age 55. 38
1893646 1991
659
An analysis of lymphocyte 3H-N-methyl-scopolamine binding in neurological patients. Evidence of altered binding in Alzheimer's disease. 38
1884177 1991
660
Assessment of competency: the role of neurobehavioral deficits. 38
2058875 1991
661
Tin and fatty acids in dementia. 38
1946550 1991
662
Dementia: case ascertainment in a community survey. 38
2071834 1991
663
Platelet membrane fluidity in Alzheimer's disease and multi-infarct dementia: a spin label study. 38
1656688 1991
664
Prospective neuropathological validation of Hachinski's Ischaemic Score in dementias. 38
1895120 1991
665
Calcium and phosphorus levels in serum and CSF in dementia. 38
1961355 1991
666
The WAIS-R profile as a cognitive marker of Alzheimer's disease: a misguided venture? 38
1918292 1991
667
Automatic and effortful memory processes in elderly persons with organic brain pathology. 38
2071838 1991
668
Somatostatin cerebrospinal fluid levels in dementia. 38
1678420 1991
669
Survival of patients with dementia. 38
2037752 1991
670
Hyperkinesia, plasma corticotropin releasing hormone and ACTH in senile dementia. 38
1655106 1991
671
Leukoaraiosis correlates with cerebral hypoperfusion in vascular dementia. 38
2028490 1991
672
The prevalence of dementia in elderly Chinese. 38
1853727 1991
673
[Drug evaluation of huperzine A in the treatment of senile memory disorders]. 38
1781288 1991
674
Multi-infarct dementia, subcortical dementia, and hydrocephalus. 38
2035108 1991
675
The effects of hypertension on the nervous system. 38
2064301 1991
676
Assessment of cognitive impairment: the role of CT. 38
2070294 1991
677
Binswanger's disease: neither Binswanger's nor a disease. 38
1865221 1991
678
Prolactin responses to thyrotropin-releasing hormone in multi-infarct dementia and senile dementia of the Alzheimer type. 38
1906673 1991
679
Medullary arteries in aging and dementia. 38
2024272 1991
680
Late onset dementia with argyrophilic grains and subcortical tangles or atypical progressive supranuclear palsy? 38
1929210 1991
681
Hypertension and the risk of dementia in the elderly. 38
2006654 1991
682
CSF monoamine metabolites, cholinesterases and lactate in the adult hydrocephalus syndrome (normal pressure hydrocephalus) related to CSF hydrodynamic parameters. 38
1709421 1991
683
Elevated urinary free cortisol in patients with dementia. 38
2052129 1991
684
Cerebral hypoperfusion correlates with mild and parenchymal loss with severe multi-infarct dementia. 38
1856730 1991
685
A three-year follow-up study of age-related dementia in an urban area of Beijing. 38
2017918 1991
686
SIDAM--A structured interview for the diagnosis of dementia of the Alzheimer type, multi-infarct dementia and dementias of other aetiology according to ICD-10 and DSM-III-R. 38
2047500 1991
687
Imaging of degenerative brain disorders. 38
2025508 1991
688
SLE and multi-infarct dementia. 38
2012934 1991
689
[Clinical findings in Alzheimer dementia and multi-infarct dementia]. 38
2038886 1991
690
Multi-infarct dementia. 38
1753251 1991
691
Diagnosis of multi-infarct dementia. 38
2059403 1991
692
Multi-infarct dementia: a reappraisal. 38
2059408 1991
693
Epidemiology of multi-infarct dementia. 38
2059410 1991
694
Pathogenetic basis of vascular dementia. 38
2059412 1991
695
[EEG studies in Alzheimer dementia and multi-infarct dementia at various times of the day]. 38
2038888 1991
696
Behavioral neurology of multi-infarct dementia. 38
2059404 1991
697
Multi-infarct dementia: prevention and treatment. 38
2059406 1991
698
Cerebral blood flow and metabolism studies in multi-infarct dementia. 38
2059405 1991
699
Cerebral blood flow and metabolism in aging and dementia. 38
1913708 1991
700
Neuropathologically confirmed Alzheimer's disease: clinical diagnoses in 394 cases. 38
2054048 1991
701
Positron emission tomography in the differential diagnosis of organic dementias. 38
1753242 1991
702
[Familial subcortical dementia with arteriopathic leukoencephalopathy. A clinico-pathological case]. 38
1853035 1991
703
The pathological basis of multi-infarct dementia. 38
2059411 1991
704
[The confused and the demented patient as a problem in neuro-rehabilitation. Old-age rehabilitation]. 38
1763514 1991
705
Erythrocyte membrane characteristics indicate abnormal cellular aging in patients with Alzheimer's disease. 38
2002877 1991
706
Decreased cerebral glucose metabolism associated with mental deterioration in multi-infarct dementia. 38
1922743 1991
707
Study of the P300 and cerebral maps in subjects with multi-infarct dementia treated with cytidine. 38
2006235 1991
708
EEG brain mapping in diagnostic and therapeutic assessment of dementia. 38
1781975 1991
709
Delusions in dementia syndromes: investigation of behavioral and neuropsychological correlates. 38
1821254 1991
710
[Mild forms of multi-infarct dementia: effectiveness of cerebrolysin]. 38
1767322 1991
711
Clinical and epidemiological aspects of dementia in the elderly. 38
1753250 1991
712
Evaluation of dementia in subcortical arteriosclerotic encephalopathy (Binswanger's disease). 38
1834189 1991
713
Longitudinal measurement of cerebral perfusion in patients with multi-infarct dementia. 38
26486265 1991
714
SPECT in the diagnosis of Alzheimer's disease and multi-infarct-dementia. 38
1651190 1991
715
Cerebral magnetic resonance imaging compared in Alzheimer's and multi-infarct dementia. 38
7580172 1991
716
Experimental basis of multi-infarct dementia: memory impairments in rodent models of ischemia. 38
2059402 1991
717
Leuko-araiosis. 38
1817028 1991
718
[Alzheimer's disease and vascular dementia: comparative pathologic vascular structure of the cerebral cortex and white matter of the brain]. 38
1665645 1991
719
Severe atrophy of amygdala and hippocampus in both Alzheimer's disease and multi-infarct dementia. 38
2103656 1990
720
Signal-detection analysis of nonverbal recognition memory in dementia. 38
2087378 1990
721
The validity of animal models in the search for drugs for the aging brain. 38
2096830 1990
722
Limbic system, the main focus of dementia syndrome--a study with MRI and PET. 38
2103658 1990
723
Comparison of I-123 IMP and Tc-99m HMPAO SPECT studies with PET in dementia. 38
2083138 1990
724
A review of screening instruments for assessing cognition and mental status in older adults. 38
2255423 1990
725
Depression in dementia of the Alzheimer type and in multi-infarct dementia. 38
2221160 1990
726
Reduced gastrointestinal absorption of calcium in dementia. 38
2285003 1990
727
The Gospel Oak Study stage II: the diagnosis of dementia in the community. 38
2284396 1990
728
Effects of co-dergocrine mesylate (Hydergine) in multi-infarct dementia as evaluated by positron emission tomography. 38
2091324 1990
729
Clinical diagnosis of Binswanger's disease. 38
2283526 1990
730
Right-left disorientation in dementia of the Alzheimer type. 38
2215956 1990
731
[Diagnostic differentiation of dementia diseases by modern imaging procedures]. 38
2272595 1990
732
Vitamin B12 levels in serum and cerebrospinal fluid of people with Alzheimer's disease. 38
2260490 1990
733
[The verbal fluency test for the diagnosis of dementia]. 38
2100040 1990
734
[P300 and dementia: diagnostic relevance. I]. 38
2123432 1990
735
[Autonomic nervous functions in Alzheimer type and multi-infarct dementia--a hemodynamic study]. 38
2265501 1990
736
Arteriolosclerotic leucoencephalopathy in the elderly and its relation to white matter lesions in Binswanger's disease, multi-infarct encephalopathy and Alzheimer's disease. 38
2230830 1990
737
Distribution of major dementias by race and sex in South Carolina. 38
2214681 1990
738
Diabetes mellitus as a risk factor for stroke. 38
2382156 1990
739
[Multiple hemorrhagic cerebral amyloid angiopathy associated with leukoencephalopathy]. 38
2223264 1990
740
The dexamethasone suppression test in dementia: a review of the literature. 38
2282129 1990
741
Delusional depression responding to clomipramine in Binswanger's disease. 38
2366061 1990
742
What contribution can the Hachinski Ischemic Scale make to the differential diagnosis between multi-infarct dementia and primary degenerative dementia? 38
15374494 1990
743
Is multi-infarct dementia representative of vascular dementias? A retrospective study. 38
1699387 1990
744
Substance P-like immunoreactivity, choline acetyltransferase activity and cholinergic muscarinic receptors in Alzheimer's disease and multi-infarct dementia. 38
1698512 1990
745
[Studies of cerebral blood flow and metabolism in patients with senile dementia of the Alzheimer's type and diagnostic evaluation of the dementing illnesses by positron emission tomography]. 38
2376611 1990
746
Clinicopathologic correlations of cranial magnetic resonance imaging of periventricular white matter. 38
2345614 1990
747
[Diffuse bilateral periventricular hyperintensity of unknown origin on MRI spin-echo sequence. Cognitive function and regional cerebral blood flow]. 38
2376613 1990
748
Course characteristics in the differentiation of dementia of the Alzheimer type and multi-infarct dementia. 38
2378248 1990
749
Effects of atropine on learning and memory functions in dementia. 38
2357705 1990
750
The diagnosis of dementia: demographic characteristics. 38
2354792 1990
751
Efficacy of xantinolnicotinate in patients with dementia. 38
2197635 1990
752
Encoding preferences in memory in dementia. 38
2364205 1990
753
Giant cell (temporal) arteritis: a treatable cause of multi-infarct dementia. 38
2330100 1990
754
Coexistence of Alzheimer's disease and multi-infarct dementia diagnosed by functional brain imaging with SPECT. 38
2340662 1990
755
Progression of illness in the differential diagnosis of primary dementia. 38
2316730 1990
756
Binswanger's disease: a complete translation. 38
2206260 1990
757
Prevalence of clinically diagnosed Alzheimer's disease and other dementing disorders: a door-to-door survey in Appignano, Macerata Province, Italy. 38
2320236 1990
758
Plasma lipoprotein profiles and the distribution of high-density lipoprotein subfractions in the elderly: the effect of Alzheimer's disease and multi-infarct dementia. 38
2379739 1990
759
Pattern of language impairment is different in Alzheimer's disease and multi-infarct dementia. 38
1693304 1990
760
Insight for impairment in independent living skills in Alzheimer's disease and multi-infarct dementia. 38
2341561 1990
761
Effects of language disturbances on premorbid estimates of IQ in mild dementia. 38
29022432 1990
762
White matter lucencies in multi-infarct dementia: a somatosensory evoked potentials and CT study. 38
2327242 1990
763
Determination of amyloid beta protein precursors harboring active form of proteinase inhibitor domains in cerebrospinal fluid of Alzheimer's disease patients by trypsin-antibody sandwich ELISA. 38
2106318 1990
764
[Comparative psychological test studies of the intellectual ability of Parkinson patients]. 38
2320195 1990
765
Leuko-araiosis, cerebral atrophy, and cerebral perfusion in normal aging. 38
2302088 1990
766
Serum lipoprotein pattern variations in dementia and ischemic stroke. 38
2330821 1990
767
[The use of positron-emission tomography in psychiatry]. 38
1981625 1990
768
Assessing utility of single photon emission computed tomography (SPECT) scan in Alzheimer disease: correlation with cognitive severity. 38
2317335 1990
769
Organic personality disorder in dementia syndromes: an inventory approach. 38
2136084 1990
770
Transcranial Doppler sonography as a diagnostic tool in vascular dementia. 38
2187699 1990
771
[Diagnostic criteria and clinical course of multi-infarct dementia]. 38
2284359 1990
772
Methodological problems of clinical trials in multi-infarct dementia. 38
2215847 1990
773
Long-term experience of a trial in multi-infarct dementia. 38
2215848 1990
774
Personality alterations in multi-infarct dementia. 38
2247570 1990
775
The decline and resurgence of vascular dementia. 38
2403832 1990
776
MRI and neuropsychological correlates of dementia in Binswanger's disease. 38
14589547 1990
777
The contribution of computerized tomography to the differential diagnosis of confusion in elderly patients. 38
2316425 1990
778
Low diagnostic yield in a memory disorders clinic. 38
2101303 1990
779
Binswanger's disease: some neuropsychological considerations. 38
2346585 1990
780
Cholinergic modulation of growth hormone-releasing hormone effects on growth hormone secretion in dementia. 38
1983729 1990
781
CSF beta-endorphin, HVA and 5-HIAA of dementia of the Alzheimer type and Binswanger's disease in the elderly. 38
1697333 1990
782
Binswanger's disease or artifact: a clinical, neuroimaging, and pathological study of periventricular white matter changes in Alzheimer's disease. 38
2294663 1990
783
[Cerebral white matter bundle alterations in patients with dementia of Alzheimer type and patients with multi-infarct dementia--magnetic resonance imaging study]. 38
2331816 1990
784
[Neuropathologic study of 50 cases of senile dementia]. 38
2077618 1990
785
Regional cerebral blood flow study with 99mTc-hexamethyl-propyleneamine oxime single photon emission computed tomography in Alzheimer's and multi-infarct dementia. 38
2269322 1990
786
Pathological findings correlated with magnetic resonance imaging in subcortical arteriosclerotic encephalopathy (Binswanger's disease). 38
2614428 1989
787
Nutrition and dementia. 38
2687349 1989
788
[Multi-infarct dementia. Current knowledge concerning pathogenesis and therapy]. 38
2693173 1989
789
[Problems in CT diagnosis of the aging brain]. 38
2692069 1989
790
Predictors of survival in clinically diagnosed Alzheimer's disease and multi-infarct dementia. 38
2818256 1989
791
Magnetic resonance imaging in Alzheimer's disease, multi-infarct dementia, alcoholic dementia and Korsakoff's psychosis. 38
2596343 1989
792
[Multi-infarct dementia in the very elderly]. 38
2618101 1989
793
Computed tomography, electroencephalography, and clinical features in the differential diagnosis of senile dementia. A prospective clinicopathologic study. 38
2818257 1989
794
[How homogenous are clinical samples? Comments on the contribution by Raissa S. Jazemirskaja: Multi-infarct dementia in very elderly patients]. 38
2618102 1989
795
[The study of dementia patients who showed intellectual improvement after admission to a hospital where they could be given special therapy for dementia]. 38
2634124 1989
796
[Multi-infarct dementia associated with antiphospholipid antibodies. Presentation of 2 cases]. 38
2607802 1989
797
[F-18 FDG PET in dementia]. 38
2601095 1989
798
Brainstem auditory evoked potentials in patients with multi-infarct dementia and dementia of the Alzheimer type. 38
2583949 1989
799
Plasma apolipoproteins in patients with multi-infarct dementia. 38
2597234 1989
800
[Cerebrovascular dementia; correlation of computed and histopathologic findings]. 38
2601093 1989
801
[Cerebral glucose metabolism in dementia (PET-FDG study)]. 38
2601096 1989
802
Cerebral revascularization: a review. 38
2677822 1989
803
[Single-photon emission-computed tomography in the differential diagnosis of dementia]. 38
2530079 1989
804
Neuropathologic correlates of leuko-araiosis. 38
2803072 1989
805
Binswanger's disease (Part II): Pathogenesis of subcortical arteriosclerotic encephalopathy and its relation to other dementing processes. 38
2699555 1989
806
Amino acid concentrations in cerebrospinal fluid in presenile and senile dementia of Alzheimer type and multi-infarct dementia. 38
2686573 1989
807
Mortality of demented patients in a geriatric institution. 38
2589919 1989
808
Patterns of performance on the Fuld Object Memory Evaluation in elderly inpatients with depression or dementia. 38
2760177 1989
809
The A-K-T ("Alters-Konzentrations-Test") a new psychometric test for geriatric patients. 38
2792862 1989
810
Binswanger's disease (Part I): The clinical recognition of subcortical arteriosclerotic encephalopathy in elderly neuropsychiatric patients. 38
2686675 1989
811
The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re-uptake site. 38
2474352 1989
812
Racial differences in the etiology of dementia and frequency of Alzheimer lesions in the brain. 38
2746686 1989
813
An epidemiological survey of age-related dementia in an urban area of Beijing. 38
2788352 1989
814
Randomized clinical trial of daily aspirin therapy in multi-infarct dementia. A pilot study. 38
2654259 1989
815
Distinguishing Alzheimer's disease from other dementias. Questionnaire responses of close relatives and autopsy results. 38
2654258 1989
816
Positron emission tomography findings in dementia disorders: contributions to differential diagnosis and objectivizing of therapeutic effects. 38
2674513 1989
817
Selective preservation of oral spelling without semantics in a case of multi-infarct dementia. 38
2758850 1989
818
Computed tomography, magnetic resonance imaging and pathological correlations in a case of Binswanger's disease. 38
2731093 1989
819
The importance of cerebral lesions of vascular origin in the morphopathologic picture of old age dementia. 38
2781230 1989
820
[Binswanger's disease--a common disease of the brain and a frequent cause and component of dementia]. 38
2736596 1989
821
[An experimental expert system for the differential diagnosis of the dementia syndrome. Initial evaluation]. 38
2728097 1989
822
[Dementia evaluated by means of a mini-mental status examination. Clinical neurologic patient material]. 38
2734742 1989